<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antihelminthics in helminth‐endemic areas: effects on HIV disease progression - Means, AR - 2016 | Cochrane Library</title> <meta content="Antihelminthics in helminth‐endemic areas: effects on HIV disease progression - Means, AR - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006419.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antihelminthics in helminth‐endemic areas: effects on HIV disease progression - Means, AR - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006419.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006419.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Antihelminthics in helminth‐endemic areas: effects on HIV disease progression" name="citation_title"/> <meta content="Arianna Rubin Means" name="citation_author"/> <meta content="University of Washington" name="citation_author_institution"/> <meta content="aerubin@u.washington.edu" name="citation_author_email"/> <meta content="Paul Burns" name="citation_author"/> <meta content="University of Washington" name="citation_author_institution"/> <meta content="David Sinclair" name="citation_author"/> <meta content="Liverpool School of Tropical Medicine" name="citation_author_institution"/> <meta content="Judd L Walson" name="citation_author"/> <meta content="University of Washington" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD006419.pub4" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/04/14" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006419.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006419.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006419.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Endemic Diseases; Anthelmintics [*therapeutic use]; CD4 Lymphocyte Count; Disease Progression; HIV Infections [immunology, *parasitology, virology]; HIV‐1 [*genetics]; Health Resources; Helminthiasis [complications, *drug therapy]; Poverty Areas; RNA, Viral [analysis]; Randomized Controlled Trials as Topic; Viral Load" name="citation_keywords"/> <meta content="" name="citation_fulltext_world_readable"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006419.pub4&amp;doi=10.1002/14651858.CD006419.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="f00EizoA";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006419\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006419\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","hr","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"open-access",doi:"10.1002/14651858.CD006419.pub4",title:"Antihelminthics in helminth\\u2010endemic areas: effects on HIV disease progression",firstPublishedDate:"Apr 14, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Infectious Diseases Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006419.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006419.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006419.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006419.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006419.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006419.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006419.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006419.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006419.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006419.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1582 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006419.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-sec-0085"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-sec-0023"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-sec-0024"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-sec-0029"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-sec-0030"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-sec-0056"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-sec-0079"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/table_n/CD006419StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/table_n/CD006419StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Authors. Cochrane Database of Systematic Reviews published by John Wiley &amp; Sons, Ltd. on behalf of The Cochrane Collaboration." data-creative-commons="true" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antihelminthics in helminth‐endemic areas: effects on HIV disease progression</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/information#CD006419-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Arianna Rubin Means</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/information#CD006419-cr-0003">Paul Burns</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/information#CD006419-cr-0004">David Sinclair</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006419.pub4/information#CD006419-cr-0005">Judd L Walson</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/information/en#CD006419-sec-0093">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 14 April 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006419.pub4">https://doi.org/10.1002/14651858.CD006419.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006419-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006419-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006419-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006419-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006419-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006419-abs-0001" lang="en"> <section id="CD006419-sec-0001"> <h3 class="title" id="CD006419-sec-0001">Background</h3> <p>Helminth infections, such as soil‐transmitted helminths, schistosomiasis, onchocerciasis, and lymphatic filariasis, are prevalent in many countries where human immunodeficiency virus (HIV) infection is also common. There is some evidence from observational studies that HIV and helminth co‐infection may be associated with higher viral load and lower CD4+ cell counts. Treatment of helminth infections with antihelminthics (deworming drugs) may have benefits for people living with HIV beyond simply clearance of worm infections. </p> <p>This is an update of a Cochrane Review published in 2009 and we have expanded it to include outcomes of anaemia and adverse events. </p> </section> <section id="CD006419-sec-0002"> <h3 class="title" id="CD006419-sec-0002">Objectives</h3> <p>To evaluate the effects of deworming drugs (antihelminthic therapy) on markers of HIV disease progression, anaemia, and adverse events in children and adults. </p> </section> <section id="CD006419-sec-0003"> <h3 class="title" id="CD006419-sec-0003">Search methods</h3> <p>In this review update, we searched online for published and unpublished studies in the Cochrane Library, MEDLINE, EMBASE, CENTRAL, the World Health Organization (WHO) International Clinical Trials Registry Platform (ICRTP), ClinicalTrials.gov, and the WHO Global Health Library up to 29 September 2015. We also searched databases listing conference abstracts, scanned reference lists of articles, and contacted the authors of included studies. </p> </section> <section id="CD006419-sec-0004"> <h3 class="title" id="CD006419-sec-0004">Selection criteria</h3> <p>We searched for randomized controlled trials (RCTs) that compared antihelminthic drugs with placebo or no intervention in HIV‐positive people. </p> </section> <section id="CD006419-sec-0005"> <h3 class="title" id="CD006419-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data and assessed trials for eligibility and risk of bias. The primary outcomes were changes in HIV viral load and CD4+ cell count, and secondary outcomes were anaemia, iron deficiency, adverse events, and mortality events. We compared the effects of deworming using mean differences, risk ratios (RR), and 95% confidence intervals (CIs). We assessed the quality of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. </p> </section> <section id="CD006419-sec-0006"> <h3 class="title" id="CD006419-sec-0006">Main results</h3> <p>Eight trials met the inclusion criteria of this review, enrolling a total of 1612 participants. Three trials evaluated the effect of providing antihelminthics to all adults with HIV without knowledge of their helminth infection status, and five trials evaluated the effects of providing deworming drugs to HIV‐positive individuals with confirmed helminth infections. Seven trials were conducted in sub‐Saharan Africa and one in Thailand. </p> <p><i>Antihelminthics for people with unknown helminth infection status</i> </p> <p>Providing antihelminthics (albendazole and praziquantel together or separately) to HIV‐positive adults with unknown helminth infection status may have a small suppressive effect on mean viral load at six weeks but the 95% CI includes the possibility of no effect (difference in mean change −0.14 log<sub>10</sub> viral RNA/mL, 95% CI −0.35 to 0.07, P = 0.19; one trial, 166 participants, <i>low quality evidence)</i>. </p> <p>Repeated dosing with deworming drugs over two years (albendazole every three months plus annual praziquantel), probably has little or no effect on mean viral load (difference in mean change 0.01 log<sub>10</sub> viral RNA, 95% CI: −0.03 to −0.05; one trial, 917 participants, <i>moderate quality evidence</i> ), and little or no effect on mean CD4+ count (difference in mean change 2.60 CD4+ cells/µL, 95% CI −10.15 to 15.35; P = 0.7; one trial, 917 participants, <i>low quality evidence</i>). </p> <p><i>Antihelminthics for people with confirmed helminth infections</i> </p> <p>Treating confirmed helminth infections in HIV‐positive adults may have a small suppressive effect on mean viral load at six to 12 weeks following deworming (difference in mean change −0.13 log<sub>10</sub> viral RNA, 95% CI −0.26 to −0.00; P = 0.04; four trials, 445 participants, <i>low quality evidence</i> ). However, this finding is strongly influenced by a single study of praziquantel treatment for schistosomiasis. There may also be a small favourable effect on mean CD4+ cell count at 12 weeks after deworming in HIV‐positive populations with confirmed helminth infections (difference in mean change 37.86 CD4+ cells/µL, 95% CI 7.36 to 68.35; P = 0.01; three trials, 358 participants, <i>low quality evidence</i>). </p> <p><i>Adverse events and mortality</i> </p> <p>There is no indication that antihelminthic drugs impart additional risks in HIV‐positive populations. However, adverse events were not well reported (<i>very low quality evidence</i> ) and trials were underpowered to evaluate effects on mortality (<i>low quality evidence</i> )<i>.</i> </p> </section> <section id="CD006419-sec-0007"> <h3 class="title" id="CD006419-sec-0007">Authors' conclusions</h3> <p>There is low quality evidence that treating confirmed helminth infections in HIV‐positive adults may have small, short‐term favourable effects on markers of HIV disease progression. Further studies are required to confirm this finding. Current evidence suggests that deworming with antihelminthics is not harmful, and this is reassuring for the routine treatment of confirmed or suspected helminth infections in people living with HIV in co‐endemic areas. </p> <p>Further long‐term studies are required to make confident conclusions regarding the impact of presumptively deworming all HIV‐positive individuals irrespective of helminth infection status, as the only long‐term trial to date did not demonstrate an effect. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006419-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006419-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006419-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006419-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD006419-abs-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006419-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD006419-abs-0003">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006419-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006419-abs-0002" lang="en"> <h3>Antihelminthics in helminth endemic areas: effects on HIV infection</h3> <p>This Cochrane Review summarizes trials that evaluated the benefits and potential risks of providing deworming drugs (antihelminthics) to people infected with human immunodeficiency virus (HIV). After we searched for relevant trials up to 29 September 2015 we included eight trials that enrolled 1612 participants. </p> <p><b>What are deworming drugs and why might they delay HIV disease progression</b> </p> <p>Deworming drugs are used to treat a variety of human helminth infections, such as soil‐transmitted helminths, schistosomiasis, onchocerciasis, and lymphatic filariasis. In areas where these infections are common, the World Health Organization currently recommends that targeted populations are routinely treated every six to 12 months without prior confirmation of an individual's infection status. The use of empiric therapy, or treating all at‐risk populations presumptively, is preferred to test‐and‐treat strategies because deworming drugs are inexpensive and well tolerated. Additionally, a strategy of testing before treatment is considered less cost‐effective given that available diagnostic tests are relatively expensive and can exhibit poor sensitivity. </p> <p>Helminth infections are known to affect the human immune system. In people with HIV, some studies have suggested that helminth infections may reduce the number of CD4+ cells (which are a critical part of the immune response to HIV) and compromise a person's ability to control HIV viral replication. Thus, treatment of helminth infections could have important benefits for people living with HIV beyond the benefits observed in the general population as a result of deworming. </p> <p><b>What the evidence in this review suggests</b> </p> <p>Treating all HIV‐positive adults with deworming drugs without knowledge of their helminth infection status may have a small suppressive effect on viral load at six weeks (<i>low quality evidence</i> ), but repeated dosing over two years appears to have little or no effect on either viral load (<i>moderate quality evidence</i> ) or CD4+ cell count (<i>low quality evidence</i>). These findings are based on two included studies. </p> <p>Providing deworming drugs to HIV‐positive adults with diagnosed helminth infection may result in a small suppressive effect on mean viral load at six to 12 weeks (<i>low quality evidence</i> ) and a small favourable effect on mean CD4+ cell count at 12 weeks (<i>low quality evidence</i>). However, these findings are based on small studies and are strongly influenced by a single study of praziquantel for schistosomiasis. Further studies from different settings and populations are needed for confirmation. </p> <p>Adverse events were not well reported (<i>very low quality evidence),</i> and trials were too small to evaluate the effects on mortality (<i>low quality evidence</i> ). However there is no suggestion that deworming drugs are harmful for HIV‐positive individuals<i>.</i> </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006419-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006419-sec-0085"></div> <h3 class="title" id="CD006419-sec-0086">Implications for practice</h3> <section id="CD006419-sec-0086"> <p>There is low quality evidence that treating confirmed helminth infections in HIV‐positive adults has a short‐term favourable effect on markers of HIV disease progression. Further studies are necessary to confirm this finding. However, there is no evidence that deworming is harmful. This is reassuring for the routine treatment of confirmed or suspected helminth infections in people living with HIV in co‐endemic areas. </p> <p>Further long‐term studies would be required to make conclusions about the likely impact of a policy of deworming all HIV‐positive individuals irrespective of helminth infection status (i.e. preventive chemotherapy) as the only trial to date did not demonstrate an effect. </p> <p>Given the large favourable effect of ART on HIV disease progression, the additive effect of regular deworming, if any, is unknown. </p> </section> <h3 class="title" id="CD006419-sec-0087">Implications for research</h3> <section id="CD006419-sec-0087"> <p>Further long‐term studies are required to make conclusions regarding the likely impact of deworming all HIV‐positive individuals irrespective of helminth infection status, as the only trial to date did not demonstrate an effect. </p> <p>Future RCTs should consider measuring both helminth infection status and long‐term HIV disease progression outcomes repeatedly between baseline and end line to understand how disease progression changes over differential amounts of follow‐up time. These RCTs should have well‐documented and active adverse event identification. Given that deworming is often targeted at preschool and school‐age children, it is also important to identify the benefit in HIV‐positive children. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006419-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006419-sec-0023"></div> <div class="table" id="CD006419-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings for participants with unknown helminth infection status</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Deworming drugs compared with placebo for people with HIV and an unknown helminth infection status</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Participant or population:</b> HIV‐positive people </p> <p><b>Settings:</b> urban and rural areas co‐endemic for helminths and HIV </p> <p><b>Intervention:</b> deworming drugs (albendazole or praziquantel or a combination) </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Deworming drugs</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Viral load</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>At 6 weeks after a single dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>166</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<sup>1,2,3,4</sup> <br/> low </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>in the control group, the mean change in viral load was an increase of</p> <p><b>0.09 log<sub>10</sub> viral RNA</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, with deworming, there was a suppressive effect on mean viral load of</p> <p><b>0.14 log<sub>10</sub> viral RNA</b> </p> <p>(0.35 benefit to 0.07 harm)</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>At 2 years after multiple doses</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>917</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<sup>1,2,5,6</sup> <br/> moderate </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the control group, the mean viral load increased by</p> <p><b>0.03 log<sub>10</sub> viral RNA</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, with deworming, there was a suppressive effect on mean viral load of</p> <p><b>0.01 log<sub>10</sub> viral RNA</b> </p> <p>(0.03 benefit to 0.05 harm)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>CD4+ cell count</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>At 2 years after multiple doses</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>917</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<sup>1,2,4,5</sup> <br/> low </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the control group, the mean CD4+ cell count reduced by</p> <p><b>37.3 CD4+ cells/µL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, with deworming, there was a favourable effect on mean CD4+ cell count of </p> <p><b>2.60 CD4+ cells/µL</b> </p> <p>(15.35 benefit 10.15 harm)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (for example, the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>RNA:</b> ribonucleic acid; <b>HIV:</b> human immunodeficiency virus. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>1</sup>No serious risk of bias: this single trial was at low risk of selection bias.<br/> <sup>2</sup>No serious inconsistency: this was not applicable as there was only a single trial.<br/> <sup>3</sup>We downgraded by 1 for serious indirectness: this single trial is based upon a specific sample of pregnant women treated with albendazole or praziquantel, or both. The overall finding of an effect cannot be easily generalized to all populations or settings.<br/> <sup>4</sup>We downgraded by 1 for imprecision: the 95% CI includes potentially clinically important differences as well as no effect. Further larger studies are needed.<br/> <sup>5</sup>We downgraded by 1 for serious indirectness: this trial was conducted in three sites in rural and urban Kenya. Helminth infection was expected to be high but was not assessed at baseline. The findings are not easily generalized to all helminth endemic settings.<br/> <sup>6</sup>No serious imprecision: the 95% CI includes no effect but is narrow around the estimate and excludes clinically important differences. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006419-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings for participants with confirmed helminth infections</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Deworming drugs compared with placebo for people with HIV and confirmed helminth infections</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Participant or population:</b> HIV‐positive people with proven helminth infection </p> <p><b>Settings:</b> urban and rural areas co‐endemic for helminths and HIV </p> <p><b>Intervention:</b> deworming drugs (albendazole, praziquantel, albendazole and praziquantel, or diethylcarbamazine) </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (trials)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Deworming drugs</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Viral load</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>At 6 to 12 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>445</p> <p>(4 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1,2,3,4</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the control groups, the mean change in viral load ranged from</p> <p><b>a 0.13 decrease to an increase of 0.21 log<sub>10</sub> viral RNA</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, with deworming, there was a small suppressive effect on mean viral load of </p> <p><b>0.13 log<sub>10</sub> viral RNA</b> </p> <p>(0.26 benefit to 0.00 benefit)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>CD4+ cell count</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>At 6 to 12 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>358</p> <p>(3 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2,5,6,7</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the control groups, the mean change in CD4+ cell count ranged from</p> <p><b>a decrease of 68 to an increase of 45 CD4+ cells/µL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, with deworming, there was favourable effect on mean CD4+ cell count of</p> <p><b>37.86 CD4+ cells/µL</b> </p> <p>(7.36 benefit to 68.35 benefit)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (for example, the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>RNA:</b> ribonucleic acid; <b>HIV:</b> human immunodeficiency virus. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>1</sup>We downgraded by 1 for serious risk of bias: of the five studies, only one had CIs that excluded the possibility of no effect and this study was at high risk of selection bias.<br/> <sup>2</sup>No serious inconsistency: statistical heterogeneity was low.<br/> <sup>3</sup>We downgraded by 1 for serious indirectness: the only trial for which the CIs excluded the possibility of no effect administered praziquantel to people with schistosomiasis. The overall finding of an effect cannot be easily generalized to all deworming drugs, helminth infections, or settings.<br/> <sup>4</sup>No serious imprecision: the overall 95% CI is wide and includes both clinically important effects and no effect. However, as potential harm is excluded, we did not further downgrade the evidence.<br/> <sup>5</sup>No serious risk of bias: one trial was at high risk of selection bias, but excluding this trial did not substantially change the result.<br/> <sup>6</sup>We downgraded by 1 for serious indirectness: the included trials are from a very limited number of settings and participants. The overall finding is not easily generalized to all deworming drugs, helminth infections, or settings, and further trials are needed.<br/> <sup>7</sup>We downgraded by 1 for imprecision: the 95% CI is wide and includes potentially clinically important differences as well as no effect. Further larger studies are needed. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006419-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings for secondary outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Deworming drugs compared with placebo for people with HIV and both known and unknown helminth infection status</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Participant or population:</b> HIV‐positive people </p> <p><b>Settings:</b> urban and rural areas co‐endemic for helminths and HIV </p> <p><b>Intervention:</b> deworming drugs (albendazole, praziquantel, albendazole and praziquantel, or diethylcarbamazine) </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Albendazole</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Iron deficiency (serum ferritin)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>log<sub>10</sub> mean increase of 0.04 µg/L </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>log<sub>10</sub> mean increase of 0.07 µg/L </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Deworming drugs associated with a 0.03 higher µg/L log<sub>10</sub> mean ferritin measure (0.30 lower to 0.35 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<sup>1,2,3,4</sup> <br/> very low </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anaemia (serum haemoglobin)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Increase in 0.15 g/dL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Decrease in 0.10 g/dL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Deworming drugs associated with a 0.25 lower g/dL haemoglobin</p> <p>(0.58 lower to 0.08 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<sup>2,4,5,6</sup> <br/> very low </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>52 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.77</b> </p> <p>(0.52 to 1.14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1627</p> <p>(5 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>7,8,9,10</sup> <br/> low </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.23</b> </p> <p>(0.53 to 2.83)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1649</p> <p>(7 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<sup>4,9,11,12</sup> <br/> very low </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>HIV:</b> human immunodeficiency virus. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>No serious risk of bias: this single trial was at risk of selection bias. However, the outcome is an objective laboratory measure. We did not downgrade the quality of the evidence.<br/> <sup>2</sup>No serious inconsistency: not applicable as this is a single trial.<br/> <sup>3</sup>We downgraded by 2 for serious indirectness: this single trial is based upon a very small sample size of people treated with diethylcarbamazine for lymphatic filariasis. The overall finding of an effect can not be easily generalized to all deworming drugs, helminth infections, or settings.<br/> <sup>4</sup>We downgraded by 1 for imprecision: the 95% CI is wide and includes potentially clinically important differences as well as no effect. Larger studies are needed.<br/> <sup>5</sup>We downgraded by 1 for serious risk of bias: this single trial was at high risk of selection bias.<br/> <sup>6</sup>Downgraded by 1 for serious indirectness: this single trial is based upon a very small sample size of people treated with praziquantel for schistosomiasis. The overall finding of an effect can not be easily generalized to all deworming drugs or helminth infections or settings.<br/> <sup>7</sup>No serious risk of bias: although some of the trials are at risk of selection bias the outcome is an objective measure. We did not downgrade the evidence.<br/> <sup>8</sup>No serious inconsistency: statistical heterogeneity was low.<br/> <sup>9</sup>No serious indirectness: these trials took place in different settings, with different drugs, and with different helminth infections present. However, effects of treatment were consistent across the trials.<br/> <sup>10</sup>We downgraded by 2 for imprecision: the 95% CI is wide and includes potentially clinically important differences as well as no effect. Additionally the trials were not powered to detect changes in the rare outcome of mortality. A trial in which 3% of controls died would require a sample size of 7648 participants to attain 80% power to detect a 33% reduction in mortality.<br/> <sup>11</sup>We downgraded by 2 for serious risk of bias: it is unclear how some of the trial authors defined adverse events and thus there is risk of bias in outcome assessment.<br/> <sup>12</sup>No serious inconsistency: however, the analysis has an I² statistic value of 34%, which may represent low to moderate heterogeneity. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006419-sec-0024" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006419-sec-0024"></div> <section id="CD006419-sec-0025"> <h3 class="title" id="CD006419-sec-0025">Description of the condition</h3> <p>Helminths, which include the soil‐transmitted helminths (STH), schistosomiasis, onchocerciasis, and lymphatic filariasis (LF), infect nearly one‐quarter of the world’s population (<a href="./references#CD006419-bbs2-0074" title="WHO . Soil‐transmitted helminth infections: fact sheet. April 2014. http://www.who.int/mediacentre/factsheets/fs366/en/(accessed February 2015). ">WHO 2014</a>). Communities with the highest helminth prevalence are often also areas with high prevalence of human immunodeficiency virus (HIV), and over half of HIV‐positive people living in helminth endemic areas are estimated to be co‐infected with at least one helminth infection (<a href="./references#CD006419-bbs2-0070" title="UNAIDS . 2007 AIDS Epidemic Update. http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf (accessed 1 August 2015). ">UNAIDS 2007</a>). </p> <p>Helminth infections have a significant effect on the human immune system, and it is hypothesized that helminth infections may modulate the host's ability to control the HIV virus (<a href="./references#CD006419-bbs2-0060" title="LawnSD , ButeraST , FolksTM . Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clinical Microbiology Reviews2001;14(4):753‐77. ">Lawn 2001</a>; <a href="./references#CD006419-bbs2-0062" title="ModjarradK , VermundSH . Effect of treating co‐infections on HIV‐1 viral load: a systematic review. The Lancet. Infectious Diseases2010;10(7):455‐63. ">Modjarrad 2010</a>). More specifically, studies have shown that amongst HIV‐positive individuals with helminth co‐infections. </p> <p> <ul id="CD006419-list-0001"> <li> <p>There may be a more rapid decline in the CD4+ T‐cells responsible for immunologic function in HIV‐positive people, and increased cellular susceptibility to HIV infection (<a href="./references#CD006419-bbs2-0050" title="EggenaMP , BarugahareB , OkelloM , MutyalaS , JonesN , MaY , et al. T cell activation in HIV‐seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection. The Journal of Infectious Diseases2005;191(5):694‐701. ">Eggena 2005</a>; <a href="./references#CD006419-bbs2-0069" title="Shapira‐NahorO , KalinkovichA , WeismanZ , GreenbergZ , NahmiasJ , ShapiroM , et al. Increased susceptibility to HIV‐1 infection of peripheral blood mononuclear cells from chronically immune‐activated individuals. AIDS1998;12(13):1731‐3. ">Shapira‐Nahor 1998</a>). </p> </li> <li> <p>CD4+ and CD8 T‐cells and monocytes may exhibit increased expression of HIV chemokine co‐receptors (<a href="./references#CD006419-bbs2-0048" title="ChachageM , PodolaL , ClowesP , NsojoA , BauerA , MgayaO , et al. Helminth‐associated systemic immune activation and HIV co‐receptor expression: response to albendazole/praziquantel treatment. PLoS Neglected Tropical Diseases2014;8(3):e2755. ">Chachage 2014</a>; <a href="./references#CD006419-bbs2-0060" title="LawnSD , ButeraST , FolksTM . Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clinical Microbiology Reviews2001;14(4):753‐77. ">Lawn 2001</a>; <a href="./references#CD006419-bbs2-0056" title="KalinkovichA , WeismanZ , BentwichZ . Chemokines and chemokine receptors: role in HIV infection. Immunology Letters1999;68(2‐3):281‐7. ">Kalinkovich 1999</a>; <a href="./references#CD006419-bbs2-0057" title="KalinkovichA , BorkowG , WeismanZ , TsimanisA , SteinM , BentwichZ . Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: environmental and constitutive factors. Clinical Immunology2001;100(1):107‐17. ">Kalinkovich 2001</a>; <a href="./references#CD006419-bbs2-0067" title="SecorWE , ShahA , MwinziPM , NdengaBA , WattaCO , KaranjaDM . Increased density of human immunodeficiency virus type 1 coreceptors CCR5 and CXCR4 on the surfaces of CD4(+) T cells and monocytes of patients with Schistosoma mansoni infection. Infection and Immunity2003;71(11):6668–71. ">Secor 2003</a>). </p> </li> <li> <p>There may be increased suppression of the antiviral T helper (Th)1 lymphocyte due to helminth‐associated Th2 lymphocyte propagation (<a href="./references#CD006419-bbs2-0045" title="BorkowG , BentwichZ . HIV and helminth co‐infection: is deworming necessary?. Parasite Immunology2006;28(11):605‐12. ">Borkow 2006</a>; <a href="./references#CD006419-bbs2-0046" title="BrownM , MawaPA , KaleebuP , ElliottAM . Helminths and HIV infection: epidemiological observations on immunological hypotheses. Parasite Immunology2006;28(11):613‐23. ">Brown 2006</a>; <a href="./references#CD006419-bbs2-0059" title="KinterAL , HorakR , SionM , RigginL , McNallyJ , LinY , et al. CD25+ regulatory T cells isolated from HIV‐infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV‐specific CD8+ T cells in vitro. AIDS Research and Human Retroviruses2007;23(3):438‐50. ">Kinter 2007</a>). </p> </li> <li> <p>There may be higher levels of eosinophilia, increased immunoglobulin (Ig) E levels, and stimulation of other immunosuppressive cytokine responses (<a href="./references#CD006419-bbs2-0044" title="BentwichZ , WeismanZ , MorozC , Bar‐YehudaS , KalinkovichA . Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections?. Clinical and Experimental Immunology1996;103(2):239‐43. ">Bentwich 1996</a>; <a href="./references#CD006419-bbs2-0009" title="BlishCA , SangaréL , HerrinBR , RichardsonBA , John‐StewartG , WalsonJL . Changes in plasma cytokines after treatment of Ascaris lumbricoides infection in individuals with HIV‐1 infection. The Journal of Infectious Diseases2010;201(12):1816‐21. ">Blish 2010</a>). </p> </li> </ul> </p> <p>In HIV‐positive individuals, co‐infection with helminths may lead to the accelerated destruction of the host immune system and earlier onset of acquired immunodeficiency syndrome (AIDS)‐defining illnesses and death (<a href="./references#CD006419-bbs2-0063" title="NesheimSR , KapogiannisBG , SoeMM , SullivanKM , AbramsE , FarleyJ , et al. Trends in opportunistic infections in the pre‐ and post‐highly active antiretroviral therapy eras among HIV‐infected children in the Perinatal AIDS Collaborative Transmission Study, 1986‐2004. Pediatrics2007;120(1):100‐9. ">Nesheim 2007</a>). Even amongst HIV‐positive patients treated with antiretroviral (ART) drugs for HIV, helminth infections may adversely influence HIV clinical outcomes (<a href="./references#CD006419-bbs2-0023" title="IvanE , CrowtherNJ , MutimuraE , RucogozaA , JanssenS , NjunwaKK , et al. Effect of deworming on disease progression markers in HIV‐1‐infected pregnant women on antiretroviral therapy: a longitudinal observational study from Rwanda. Clinical Infectious Diseases2015;60(1):135‐42. ">Ivan 2015</a>). Given these profound effects on host immunity, helminth infections have been suggested to play an important role in the pathogenesis of HIV in Africa (<a href="./references#CD006419-bbs2-0043" title="BentwichZ , KalinkovichA , WeismanZ . Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunology Today1995;16(4):187‐91. ">Bentwich 1995</a>; <a href="./references#CD006419-bbs2-0051" title="FinchamJE , MarkusMB , AdamsVJ . Could control of soil‐transmitted helminthic infection influence the HIV/AIDS pandemic. Acta Tropica2003;86(2‐3):315‐33. ">Fincham 2003</a>). </p> </section> <section id="CD006419-sec-0026"> <h3 class="title" id="CD006419-sec-0026">Description of the intervention</h3> <p>Current World Health Organization (WHO) guidelines recommend that high‐risk populations living in endemic areas participate in regular mass drug administration with antihelminthic medicines (deworming drugs) without the need for prior confirmatory diagnostic testing. This is also known as preventive chemotherapy. In settings where community prevalence of STH infections exceed 20%, the WHO recommends annual treatment with albendazole or mebendazole for all preschool‐age children, school‐age children, and pregnant women in their second and third trimester (<a href="./references#CD006419-bbs2-0073" title="World Health Organization. Preventive chemotherapy in human helminthiasis. Coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization, 2006. ">WHO 2006</a>). </p> <p>The rationale for mass treatment rather than a test and treat approach is the safety of the drugs, low cost of the drugs (often donated by pharmaceutical companies), the relatively high cost of diagnostic testing, and the high prevalence of infection in some areas. The cost of these programmes is estimated to be as low as USD 0.25 per treatment, including delivery costs (<a href="./references#CD006419-bbs2-0047" title="BundyDAP , KremerM , BleakleyH , JukesMCH , MiguelE . Deworming and development: asking the right questions, asking the questions right. PLoS Neglected Tropical Diseases2009;3(1):e362. [10.1371/ journal.pntd.0000362] ">Bundy 2009</a>; <a href="./references#CD006419-bbs2-0065" title="Partnership for Child Development. Cost of school‐based treatment in Tanzania. Health Policy and Planning1998;13(4):384‐96. ">Partnership for Child Development 1998</a>). Mass deworming programs are scaling up rapidly in part due to the WHO NTD Roadmap for Implementation and the 2012 WHO‐endorsed London Declaration, which calls for the control or elimination of 10 neglected tropical diseases including STHs, schistosomiasis, LF, and onchocerciasis by 2020 (<a href="./references#CD006419-bbs2-0071" title="Uniting to CombatNTDs . The London Declaration. http://unitingtocombatntds.org/sites/default/files/resource_file/london_declaration_on_ntds.pdf (accessed 1 August 2015). ">Uniting to Combat NTDs 2012</a>). </p> <p>In research settings deworming treatment may require prior confirmatory testing or treatment may be delivered empirically as customary in preventative chemotherapy campaigns. For example, specific age groups may be targeted and recruited to receive deworming medications during community‐based household recruitment, at HIV clinics, at tuberculosis (TB) clinics, or during antenatal care. </p> </section> <section id="CD006419-sec-0027"> <h3 class="title" id="CD006419-sec-0027">How the intervention might work</h3> <p>If helminth co‐infection plays a significant detrimental role in HIV disease progression it is possible that effective treatment or prevention of helminth infections could slow the progression of HIV (<a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>; <a href="./references#CD006419-bbs2-0039" title="WoldayD , MayaanS , MariamZG , BerheN , SeboxaT , BrittonS , et al. Treatment of intestinal worms is associated with decreased HIV plasma viral load. Journal of Acquired Immune Deficiency Syndromes2002;31(1):56‐62. ">Wolday 2002</a>). Relatively modest increases in viral load (0.3 to 0.5 log<sub>10</sub> copies/mL) may increase the annual risk of progression to an AIDS‐defining illness or death by as much as 25% to 44% (<a href="./references#CD006419-bbs2-0061" title="ModjarradK , ChamotE , VermundSH . Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS2008;22(16):2179‐85. ">Modjarrad 2008</a>). Mathematical modelling suggests that a reduction in HIV‐1 ribonucleic acid (RNA) levels of 0.5 log<sub>10</sub> copies/mL could slow the onset of AIDS by 3.5 years and could delay the need for ART medications by almost a full year (<a href="./references#CD006419-bbs2-0054" title="GuptaSB , JacobsonLP , MargolickJB , RinaldoCR , PhairJP , JamiesonBD , et al. Estimating the benefit of an HIV‐1 vaccine that reduces viral load set point. The Journal of Infectious Diseases2007;195(4):546‐50. ">Gupta 2007</a>). The potential increases in HIV RNA associated with helminth co‐infection suggest that for every 100 HIV‐positive individuals with an STH infection in sub‐Saharan Africa, there could be 3.1 (95% CI: 0.1 to 14.9) excess HIV‐1 transmission events. The trend is similar for other helminth infections, with 8.5 (95% CI 0.2 to 38.6) excess HIV transmission events attributed to schistosomiasis and 13.3 (95% CI 0.3 to 89.2) to filariasis (<a href="./references#CD006419-bbs2-0042" title="BaggaleyRF , HollingsworthTD . Brief report: HIV‐1 transmissions during asymptomatic infection: exploring the impact of changes in HIV‐1 viral load due to coinfections. Journal of Acquired Immune Deficiency Syndromes2015;68(5):594‐8. ">Baggaley 2015</a>). </p> <p>Observational studies of the effects of deworming drugs on markers of HIV disease progression have had conflicting results. Several studies have noted delays in HIV disease progression following deworming (<a href="./references#CD006419-bbs2-0011" title="BrownM , MawaPA , JosephS , BukusubaJ , WateraC , WhitworthJAG , et al. Treatment of Schistosoma mansoni infection increases helminth‐specific type 2 cytokine responses and HIV‐1 loads in coinfected Ugandan adults. Journal of Infectious Diseases2005;191(10):1648‐57. ">Brown 2005</a>; <a href="./references#CD006419-bbs2-0023" title="IvanE , CrowtherNJ , MutimuraE , RucogozaA , JanssenS , NjunwaKK , et al. Effect of deworming on disease progression markers in HIV‐1‐infected pregnant women on antiretroviral therapy: a longitudinal observational study from Rwanda. Clinical Infectious Diseases2015;60(1):135‐42. ">Ivan 2015</a>; <a href="./references#CD006419-bbs2-0030" title="LankowskiAJ , TsaiAC , KanyesigyeM , BwanaM , HabererJE , WengerM , et al. Empiric deworming and CD4 count recovery in HIV‐infected Ugandans initiating antiretroviral therapy. PLoS Neglected Tropical Diseases2014;8(8):e3036. ">Lankowski 2014</a>; <a href="./references#CD006419-bbs2-0034" title="MuluA , MaierM , LiebertUG . Deworming of intestinal helminths reduces HIV‐1 subtype C viraemia in chronically co‐infected individuals. International Journal of Infectious Diseases2013;17(10):e897–901. ">Mulu 2013</a>; <a href="./references#CD006419-bbs2-0035" title="MuokEM , SimiyuEW , OcholaEA , Ng'ang'aZW , SecorWE , KaranjaDM , et al. Association between CD4+ T‐lymphocyte counts and fecal excretion of Schistosoma mansoni eggs in patients coinfected with S. mansoni and human immunodeficiency virus before and after initiation of antiretroviral therapy. American Journal of Tropical Medicine and Hygiene2013;89(1):42‐5. ">Muok 2013</a>; <a href="./references#CD006419-bbs2-0039" title="WoldayD , MayaanS , MariamZG , BerheN , SeboxaT , BrittonS , et al. Treatment of intestinal worms is associated with decreased HIV plasma viral load. Journal of Acquired Immune Deficiency Syndromes2002;31(1):56‐62. ">Wolday 2002</a> ), while others have reported no association (<a href="./references#CD006419-bbs2-0010" title="BrownM , KizzaM , WateraC , QuigleyMA , RowlandA , HighesP , et al. Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. The Journal of Infectious Diseases2004;190(10):1869‐79. ">Brown 2004</a>; <a href="./references#CD006419-bbs2-0012" title="ElliottAM , MawaPA , JosephS , NamujjuPB , KizzaM , NakiyingiJS , et al. Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV‐1 infected Ugandan adults. Transactions of the Royal Society of Tropical Medicine and Hygiene2003;97(1):103‐8. ">Elliott 2003</a>; <a href="./references#CD006419-bbs2-0022" title="HosseinipourMC , NapravnikS , JoakiG , GamaS , MbeyeN , BandaB , et al. HIV and parasitic infection and the effect of treatment among adult outpatients in Malawi. The Journal of Infectious Diseases2007;195(9):1278‐82. ">Hosseinipour 2007</a>; <a href="./references#CD006419-bbs2-0029" title="KleppaE , RamsuranV , ZuluS , KarlsenGH , BereA , PassmoreJA , et al. Effect of female genital schistosomiasis and anti‐schistosomal treatment on monocytes, CD4+ T‐cells and CCR5 expression in the female genital tract. PLoS One2014;9(6):e98593. ">Kleppa 2014</a>; <a href="./references#CD006419-bbs2-0031" title="LawnSD , KaranjaDM , MwinziP , AndoveJ , ColleyDG , FolksTM , et al. The effect of treatment of schistosomiasis on blood plasma HIV‐1 RNA concentration in coinfected individuals. AIDS2000;14(16):2437‐43. ">Lawn 2000</a>; <a href="./references#CD006419-bbs2-0033" title="ModjarradK , ZuluI , ReddenDT , NjobvuL , LaneHC , BentwichZ , et al. Treatment of intestinal helminths does not reduce plasma concentrations of HIV‐1 RNA in coinfected Zambian adults. The Journal of Infectious Diseases2005;192(7):1277‐83. ">Modjarrad 2005</a>). In the previous version of this systematic review we found some evidence from randomized controlled trials of short term benefits with deworming but also the need for further larger studies (<a href="./references#CD006419-bbs2-0078" title="WalsonJL , HerrinBR , John‐StewartG . Deworming helminth co‐infected individuals for delaying HIV disease progression. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD006419.pub3] ">Walson 2009</a>). </p> </section> <section id="CD006419-sec-0028"> <h3 class="title" id="CD006419-sec-0028">Why it is important to do this review</h3> <p>Given that a substantial number of individuals targeted by helminth control programmes may be exposed to or infected with HIV, it is important to establish the safety of deworming drugs in HIV‐positive populations and the potential for drug interactions, particularly as an increased incidence of drug reactions has been observed in patients with advanced HIV infection (<a href="./references#CD006419-bbs2-0052" title="GordinFM , SimonGL , WofsyCB , MillsJ . Adverse reactions to trimethoprim‐sulphamethoxazole in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine1984;100(4):495–9. ">Gordin 1984</a>; <a href="./references#CD006419-bbs2-0064" title="NunnP , KibugaD , GathuaS , BrindleR , ImalingatA , WasunnaK , et al. Cutaneous hypersensitivity reactions due to thiacetazone in HIV‐1 seropositive patients treated for tuberculosis. The Lancet1991;377(8742):627–30. ">Nunn 1991</a>). Available data from a recent systematic review also suggested the potential for an interaction between both mebendazole and albendazole and nucleoside reverse transcriptase inhibitors appears low, although no formal pharmacokinetic studies exist. The review also reported that interactions may exist between praziquantel and protease inhibitors via enzyme inhibition (<a href="./references#CD006419-bbs2-0068" title="SedenK , KhooS , BackD , PrevattN , LamordeM , Byakika‐KibwikaP , et al. Drug–drug interactions between antiretrovirals and drugs used in the management of neglected tropical diseases: important considerations in the WHO 2020 Roadmap and London Declaration on Neglected Tropical Diseases. AIDS2013;27(5):675‐86. ">Seden 2013</a>). </p> <p>Since the publication of our initial Cochrane Review of this topic in 2009 (<a href="./references#CD006419-bbs2-0078" title="WalsonJL , HerrinBR , John‐StewartG . Deworming helminth co‐infected individuals for delaying HIV disease progression. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD006419.pub3] ">Walson 2009</a>), deworming campaigns have been dramatically scaled up and it has become increasingly important to understand not only the effects of deworming on HIV disease progression but also the safety of treating these unique patient populations. In this update, we have expanded the scope of this Cochrane Review to include trials that evaluate the impact of deworming on anaemia and iron deficiency, as well as markers of HIV disease progression and safety. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006419-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006419-sec-0029"></div> <p>To evaluate the effects of deworming drugs (antihelminthic therapy) on markers of HIV disease progression, anaemia, and adverse events in children and adults. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006419-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006419-sec-0030"></div> <section id="CD006419-sec-0031"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006419-sec-0032"> <h4 class="title">Types of studies</h4> <p>Randomized controlled trials (RCTs) or quasi‐RCTs.</p> </section> <section id="CD006419-sec-0033"> <h4 class="title">Types of participants</h4> <p>Adults and children (older than one year of age) infected with human immunodeficiency virus (HIV)‐1 or HIV‐2 with and without documented helminth co‐infection. </p> <p>Relevant helminth‐infections included schistosomiasis (<i>Schistosomiasis mansoni</i> and <i>Schistosomiasis haematobium),</i> STH (<i>Strongyloides stercoralis</i> , <i>Ancylostoma duodenale</i> ,<i>Necator americanus</i> , <i>Trichuris trichiura</i> , <i>Ascaris lumbricoides</i> , and <i>Trichostrongylus</i> ), lymphatic filariasis (LF) (<i>Wuchereria bancrofti</i> ,<i>Brugia malayi</i> , and <i>Brugia timori</i> ), onchocerciasis (<i>Onchocerca volvulus</i> ), and other filariasis (<i>Mansonella streptocerca</i>). </p> <p>For trials that included both HIV‐positive and uninfected participants, we contacted the trial authors and requested data relevant to the HIV‐positive participants only. </p> </section> <section id="CD006419-sec-0034"> <h4 class="title">Types of interventions</h4> <section id="CD006419-sec-0035"> <h5 class="title">Intervention</h5> <p>Any antihelminthic drug therapy recommended by World Health Organization (WHO) guidelines for use in the eradication of helminth infections in humans. This included the benzimidazoles (albendazole or mebendazole), ivermectin, praziquantel, diethylcarbamazine (DEC), bithionol, oxamniquine, pyrantel, and nitazoxanide (<a href="./references#CD006419-bbs2-0073" title="World Health Organization. Preventive chemotherapy in human helminthiasis. Coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization, 2006. ">WHO 2006</a>). </p> </section> <section id="CD006419-sec-0036"> <h5 class="title">Control</h5> <p>Placebo or no treatment. For the outcome of adverse events, we also considered alternative antihelminthic drugs. </p> </section> </section> <section id="CD006419-sec-0037"> <h4 class="title">Types of outcome measures</h4> <section id="CD006419-sec-0038"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD006419-list-0002"> <li> <p>Change in plasma viral load (log<sub>10</sub>copies viral RNA/mL). </p> </li> <li> <p>Change in CD4+ T‐cell count (cells/µL).</p> </li> </ul> </p> </section> <section id="CD006419-sec-0039"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD006419-list-0003"> <li> <p>Change in CD8<sup>+</sup> T‐cell count (cells/µL). </p> </li> <li> <p>CD4+/CD8<sup>+</sup> T‐cell ratio. </p> </li> <li> <p>Adverse events associated with antihelminthic therapy (if reported in the included trials). </p> </li> <li> <p>Iron deficiency (as defined by the trial authors, based on a biomarker of iron status and tests, at 34 weeks gestation or later in pregnant populations). </p> </li> <li> <p>Anaemia (defined as haemoglobin (Hb) below 110 g/L, adjusted for altitude and smoking as appropriate). </p> </li> <li> <p>Death.</p> </li> </ul> </p> </section> </section> </section> <section id="CD006419-sec-0040"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006419-sec-0041"> <h4 class="title">Electronic searches</h4> <p>In coordination with a the Information Specialist of the Cochrane Infectious Diseases Group (CIDG), we searched MEDLINE online (1980 to 2015), EMBASE (1980 to 2015), CENTRAL (1980 to 2015), the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (all dates), and clinicaltrials.gov (1980 to 2015) using the strategies documented in <a href="#CD006419-tbl-0004">Table 1</a>, <a href="#CD006419-tbl-0005">Table 2</a>, <a href="#CD006419-tbl-0006">Table 3</a>, <a href="#CD006419-tbl-0007">Table 4</a>, and <a href="#CD006419-tbl-0008">Table 5</a>, respectively. As this is a review update, we also searched MEDLINE, EMBASE, CENTRAL, and AIDSEARCH databases using the exact search terms utilized in the previously published in <a href="./references#CD006419-bbs2-0078" title="WalsonJL , HerrinBR , John‐StewartG . Deworming helminth co‐infected individuals for delaying HIV disease progression. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD006419.pub3] ">Walson 2009</a> up to 29 September 2015 (<a href="#CD006419-tbl-0009">Table 6</a>; <a href="#CD006419-tbl-0010">Table 7</a>; <a href="#CD006419-tbl-0011">Table 8</a>; <a href="#CD006419-tbl-0012">Table 9</a>). We conducted a separate search in the WHO Global Health Library, which accesses AIM (AFRO), LILACS (AMRO/PAHO), IMEMR (EMRO), IMSEAR (SEARO), WPRIM (WPRO), WHOLIS (KMS), and SciELO resources (<a href="#CD006419-tbl-0013">Table 10</a>). </p> <div class="table" id="CD006419-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Cochrane librarian search strategy for MEDLINE</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Search (HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tiab] OR hiv‐1*[tiab] OR hiv‐2*[tiab] OR hiv1[tiab] OR hiv2[tiab] OR hiv infect*[tiab] OR human immunodeficiency virus[tiab] OR human immunedeficiency virus[tiab] OR human immuno‐deficiency virus[tiab] OR human immune‐deficiency virus[tiab] OR ((human immun*[tiab]) AND (deficiency virus[tiab])) OR acquired immunodeficiency syndrome[tiab] OR acquired immunedeficiency syndrome[tiab] OR acquired immuno‐deficiency syndrome[tiab] OR acquired immune‐deficiency syndrome[tiab] OR ((acquired immun*[tiab]) AND (deficiency syndrome[tiab])) OR "sexually transmitted diseases, Viral"[MeSH:NoExp])) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Search (randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo [tiab] OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab]) NOT (animals [mh] NOT humans [mh]) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Search (helminths[mh] OR helminth*[tiab] OR nematode*[tiab] OR worm*[tiab] OR parasites[mh] OR parasit*[tiab] OR round worm*[tiab] OR roundworm*[tiab] OR hookworm*[tiab] OR hook worm*[tiab] OR ancylostoma*[tiab] OR cestode*[tiab] OR tapeworm*[tiab] OR tape worm*[tiab] OR trematode*[tiab] OR fluke*[tiab] OR whipworm*[tiab] OR whip worm*[tiab] OR trichuris[tiab] OR ascaris[tiab] OR enterobi*[tiab] OR strongyloide*[tiab] OR mansonell*[tiab] OR taenia[tiab] schistosom*[tiab] OR necator*[tiab] OR paragonim*[tiab] OR hymenolepis[tiab] OR fasciol*[tiab] OR filariasis[tiab] OR trichostrongl*[tiab] OR microfilaria[tiab] OR parasitic diseases[mh:noexp] OR helminthiasis[mh] OR intestinal diseases, parasitic[mh]) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Search (benzimidazoles OR albendazole OR mebendazole OR ivermectin OR praziquantel OR diethylcarbamazine OR bithionol OR oxamniquine OR pyrantel OR nitazoxanide OR anthelmintic OR anthelmintics OR anthelminthic OR anthelminthics OR “anti helminthic” OR “anti helminthics” OR “anti helmintic” OR “anti helmintics” OR antihelminthic OR antihelminthics OR antihelmintic OR antihelmintics) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Search (#1 AND #2 AND #3 AND #4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Search (((#1 AND #2 AND #3 AND #4))) AND ("1980/01/01"[Date ‐ Publication] : "2015/09/29"[Date ‐ Publication]) </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006419-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Cochrane librarian search strategy for EMBASE</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'human immunodeficiency virus infection' exp OR 'human immunodeficiency virus infection':ab,ti OR 'hiv infection':ab,ti OR 'hiv infections':ab,ti OR 'human immunodeficiency virus'/exp OR 'human immunodeficiency virus':ab,ti OR hiv:ab,ti OR 'hiv 1':ab,ti OR 'hiv 2':ab,ti OR 'human immune deficiency virus':ab,ti OR 'human immuno deficiency virus':ab,ti OR 'acquired immunodeficiency syndrome':ab,ti OR 'acquired immuno deficiency syndrome':ab,ti OR 'acquired immune deficiency syndrome':ab,ti OR 'acquired immunedeficiency syndrome':ab,ti </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'randomized controlled trial'/de OR 'randomized controlled trial' OR random*:ab,ti OR trial:ti OR allocat*:ab,ti OR factorial*:ab,ti OR placebo*:ab,ti OR assign*:ab,ti OR volunteer*:ab,ti OR 'crossover procedure'/de OR 'crossover procedure'OR 'double‐blind procedure'/de OR 'double‐blind procedure' OR 'single‐blind procedure'/de OR 'single‐blind procedure' OR (doubl*NEAR/3 blind*):ab,ti OR (singl*:ab,ti AND blind*:ab,ti) OR crossover*:ab,ti OR cross+over*:ab,ti OR (crossNEXT/1 over*):ab,ti </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'animal'/de OR 'animal experiment'/de OR 'invertebrate'/de OR 'animal tissue'/de OR 'animal cell'/de OR 'nonhuman'/de </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'human'/de OR 'normal human'/de OR 'human cell'/de</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3 AND #4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3 NOT #5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2 NOT #6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'helminth'/exp OR helminth*:ab,ti OR nematode*:ab,ti OR worm*:ab,ti OR 'parasite'/exp OR parasit*:ab,ti OR roundAND worm*:ab,ti OR roundworm*:ab,ti OR hookworm*:ab,ti OR hookAND worm*:ab,ti OR ancylostoma*:ab,ti OR cestode*:ab,ti OR tapeworm*:ab,ti OR tapeAND worm*:ab,ti OR trematode*:ab,ti OR fluke*:ab,ti OR whipworm*:ab,ti OR whipAND worm*:ab,ti OR trichuris:ab,ti OR ascaris:ab,ti OR enterobi*:ab,ti OR strongyloide*:ab,ti OR mansonell*:ab,ti OR taenia:ab,ti AND schistosom*:ab,ti OR necator*:ab,ti OR paragonim*:ab,ti OR hymenolepis:ab,ti OR fasciol*:ab,ti OR filariasis:ab,ti OR trichostrongl*:ab,ti OR microfilaria:ab,ti OR 'parasitic diseases'/exp OR 'helminthiasis'/de OR 'intestine infection'/de </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'benzimidazoles'/de OR benzimidazolesOR 'albendazole'/de OR albendazoleOR 'mebendazole'/de OR mebendazoleOR 'ivermectin'/de OR ivermectinOR 'praziquantel'/de OR praziquantelOR 'diethylcarbamazine'/de OR diethylcarbamazineOR 'bithionol'/de OR bithionolOR 'oxamniquine'/de OR oxamniquineOR 'pyrantel'/de OR pyrantelOR 'nitazoxanide'/de OR nitazoxanideOR 'anthelmintic'/de OR anthelminticOR 'anthelmintics'/de OR anthelminticsOR 'anthelminthic'/de OR anthelminthicOR anthelminthicsOR 'anti helminthic'OR 'anti helminthics'OR 'anti helmintic'OR 'anti helmintics'OR antihelminthicOR antihelminthicsOR 'antihelmintic'/de OR antihelminticOR 'antihelmintics'/de OR antihelmintics </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #7 AND #8 AND #9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #7 AND #8 AND #9 AND [1‐1‐1980]/sd NOT [29‐09‐2015]/sd</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006419-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Cochrane librarian search strategy for CENTRAL</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MeSH descriptor: [HIV Infections] explode all trees</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MeSH descriptor: [HIV] explode all trees</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>hiv or hiv‐1* or hiv‐2* or hiv1 or hiv2 or (hiv near infect*) or (human immunodeficiency virus) or (human immunedeficiency virus) or (human immune‐deficiency virus) or (human immuno‐deficiency virus) or (human immune deficiency virus) or (human immuno deficiency virus) or (acquired immunodeficiency syndrome) or (acquired immunedeficiency syndrome) or (acquired immuno‐deficiency syndrome) or (acquired immune‐deficiency syndrome) or (acquired immun* deficiency syndrome) (Word variations have been searched) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MeSH descriptor: [Lymphoma, AIDS‐Related] this term only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MeSH descriptor: [Sexually Transmitted Diseases, Viral] this term only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 or #2 or #3 or #4 or #5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>[mh helminths] or helminth*:ti,ab,kw or meatode*:ti,ab,kw or worm*:ti,ab,kw or [mh parasites] or parasit*:ti,ab,kw or round worm:ti,ab,kw or roundworm:ti,ab,kw or hook worm*:ti,ab,kw or hookworm*:ti,ab,kw or ancylostoma*:ti,ab,kw or cestode*:ti,ab,kw or tapeworm*:ti,ab,kw or tape worm*:ti,ab,kw or trematode*:ti,ab,kw or fluke*:ti,ab,kw or whipworm*:ti,ab,kw or whip worm*:ti,ab,kw or trichuris:ti,ab,kw or ascaris:ti,ab,kw or enterobi*:ti,ab,kw or strongyloide*:ti,ab,kw or mansonell*:ti,ab,kw or taenia:ti,ab,kw schistosom*:ti,ab,kw or necator*:ti,ab,kw or paragonim*:ti,ab,kw or hymenolepis:ti,ab,kw or fasciol*:ti,ab,kw or filariasis:ti,ab,kw or trichostrongl*:ti,ab,kw or microfilaria:ti,ab,kw or [mh ^"parasitic diseases"] or [mh helminthiasis] or [mh ^"intestinal diseases, parasitic"] (Word variations have been searched) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>benzimidazoles or albendazole or mebendazole or ivermectin or praziquantel or diethylcarbamazine or bithionol or oxamniquine or pyrantel or nitazoxanide or anthelmintic or anthelmintics or anthelminthic or anthelminthics or "anti helminthic" or "anti helminthics" or "anti helmintic" or "anti helmintics" or antihelminthic or antihelminthics or antihelmintic or antihelmintics (Word variations have been searched) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6 and #7 and #8 Publication Year from 1980 to 2015, in Trials</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006419-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Cochrane librarian search strategy for the WHO ICTRP</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HIV AND HELMINTH</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006419-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Cochrane librarian search strategy for clinicaltrials.gov</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HIV AND HELMINTH | Interventional Studies | received from 01/01/1980 to 09/29/2015</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006419-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Search terms used in 2009 newly applied in MEDLINE</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“HIV Infections”[MeSH] OR “HIV”[MeSH] OR hiv [tw] OR hiv‐1*[tw] OR hiv‐2*[tw] OR hiv1[tw] OR hiv2[tw] OR hiv infect*[tw] OR human immunodeficiency virus[tw] OR human immunedeficiency virus[tw] OR human immunodeficiency virus[tw] OR human immune‐deficiency virus[tw] OR ((human immun*) AND (deficiency virus[tw])) OR acquired immunodeficiency syndrome[tw] OR acquired immunedeficiency syndrome[tw] OR acquired immunodeficiency syndrome[tw] OR acquired immune‐deficiency syndrome[tw] OR ((acquired immun*) AND (deficiency syndrome[tw])) OR “Sexually Transmitted Diseases, Viral”[MeSH:NoExp] </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized controlled trials [mh] OR random allocation [mh] OR double‐blind method [mh] OR single‐blind method [mh] OR clinical trial [pt] OR clinical trials [mh] OR (“clinical trial” [tw]) OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR (placebos [mh] OR placebo* [tw] OR random* [tw] OR research design [mh:noexp] OR comparative study [mh] OR evaluation studies [mh] OR follow‐up studies [mh] OR prospective studies [mh] OR control* [tw] OR prospectiv* [tw] OR volunteer* [tw]) NOT (animals [mh] NOT human [mh]) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HELMINTHS OR ROUNDWORM OR ROUND WORM OR ROUND‐WORM OR ROUNDWORMS OR ROUND WORMS OR ROUND‐WORMS OR NEMATODES OR NEMATODE OR CESTODE OR CESTODES OR TAPEWORM OR TAPE WORM OR TAPE‐WORM OR TAPEWORMS OR TAPE WORMS OR TAPE‐WORMS OR TREMATODE OR TREMATODES OR FLUKE OR FLUKES OR WORM OR WORMS OR PARASITE OR PARASITES OR ASCARIS OR TRICHURIS OR ENTEROBIUS OR STRONGYLOIDE OR STRONGYLOIDES OR ANCYLOSTOMA OR ANCYLOSTOMAS OR NECATOR OR NECATORS OR HYMENOLEPIS OR PARAGONIMUS OR FASCIOLA OR TAENIA OR HOOKWORM OR HOOK WORM OR HOOK‐WORM OR HOOKWORMS OR HOOK WORMS OR HOOK‐WORMS OR WHIPWORM OR WHIP WORM OR WHIP‐WORM OR WHIPWORMS OR WHIP WORMS OR WHIP‐WORMS OR SCHISTOSOMIASIS OR MANSONELLA OR FILARIASIS OR MICROFILARIA OR TRICHOSTRONGYLUS OR TRICHOSTRONGYLOSIS OR STRONGYLOIDEA OR PARAGONIMIASIS </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BENZIMIDAZOLES OR ALBENDAZOLE OR MEBENDAZOLE OR IVERMECTIN OR PRAZIQUANTEL OR DIETHYLCARBAMAZINE OR BITHIONOL OR OXAMNIQUINE OR PYRANTEL OR NITAZOXANIDE </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3 AND #4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #2 AND #5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #2 AND #5 Limits: Publication Date from 1980 to 2015/09/29</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006419-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Search terms used in 2009 newly applied in EMBASE</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>((’human immunodeficiency virus infection’/exp OR ’human immunodeficiency virus infection’) OR (’human immunodeficiency virus infection’/exp OR ’human immunodeficiency virus infection’)) OR ((’human immunodeficiency virus’/exp OR ’human immunodeficiency virus’) OR (’human immunodeficiency virus’/exp OR ’human immunodeficiency virus’)) OR (hiv:ti OR hiv:ab) OR (’hiv‐1’:ti OR ’hiv‐1’:ab) OR (’hiv‐2’:ti OR ’hiv‐2’:ab) OR (’human immunodeficiency virus’:ti OR ’human immunodeficiency virus’:ab) OR (’human immuno‐deficiency virus’:ti OR ’human immuno‐deficiency virus’:ab) OR (’human immunedeficiency virus’:ti OR ’human immunedeficiency virus’:ab) OR (’human immune‐deficiency virus’:ti OR ’human immune‐deficiency virus’:ab) OR (’acquired immune‐deficiency syndrome’:ti OR ’acquired immune‐deficiency syndrome’:ab) OR (’acquired immunedeficiency syndrome’:ti OR ’acquired immunedeficiency syndrome’:ab) OR (’acquired immunodeficiency syndrome’:ti OR ’acquired immunodeficiency syndrome’:ab) OR (’acquired immuno‐deficiency syndrome’:ti OR ’acquired immuno‐deficiency syndrome’:ab) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>random:ti OR random:ab OR factorial:ti OR factorial*:ab OR 'cross over':ti OR 'cross over':ab OR crossover:ti OR crossover:ab OR placebo:ti OR placebo:ab OR (double:ti AND blind:ti) OR (doubl:ab AND blind*:ab) OR (single:ti AND blind:ti) OR (single:ab AND blind:ab) OR assign:ti OR assign:ab OR allocat:ti OR allocate:ab OR volunteer:ti OR volunteer:ab OR 'crossover procedure'/exp OR 'crossover procedure' OR 'double‐blind procedure'/exp OR 'double‐blind procedure' OR 'single‐blind procedure'/exp OR 'single‐blind procedure' OR 'randomized controlled trial'/exp OR 'randomized controlled trial' </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'helminths' OR 'roundworm' OR 'round worm' OR 'round‐worm' OR roundworms OR 'round worms' OR 'round‐worms' OR nematodes OR 'nematode' OR 'cestode' OR cestodes OR 'tapeworm' OR 'tape worm' OR 'tape‐worm' OR tapeworms OR 'tape worms' OR 'tape‐worms' OR 'trematode' OR trematodes OR 'fluke' OR flukes OR 'worm' OR worms OR 'parasite' OR 'parasites' OR 'ascaris' OR 'trichuris' OR 'enterobius' OR strongyloide OR stronglyloides OR 'ancylostoma' OR ancylostomas OR 'necator' OR necators OR 'hymenolepis' OR 'paragonimus' OR 'fasciola' OR 'taenia' OR 'hookworm' OR 'hook worm' OR 'hook‐worm' OR hookworms OR 'hook worms' OR 'hook‐worms' OR 'whipworm' OR 'whip worm' OR 'whip‐worm' OR whipworms OR 'whip worms' OR 'whip‐worms' OR shistosomiasis OR 'mansonella' OR 'filariasis' OR 'microfilaria' OR 'trichostrongylus' OR trichostronglylosis OR stronglyloidea OR pargonimiasis </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>((’benzimidazoles’/exp OR ’benzimidazoles’) OR (’benzimidazoles’/exp OR ’benzimidazoles’)) OR ((’albendazole’/exp OR ’albendazole’) OR (’albendazole’/exp OR ’albendazole’)) OR ((’mebendazole’/exp OR ’mebendazole’) OR (’mebendazole’/exp OR ’mebendazole’)) OR ((’ivermectin’/exp OR ’ivermectin’) OR (’ivermectin’/exp OR ’ivermectin’)) OR ((’praziquantel’/exp OR ’praziquantel’) OR (’praziquantel’/exp OR ’praziquantel’)) OR ((’diethylcarbamazine’/exp OR ’diethylcarbamazine’) OR (’diethylcarbamazine’/exp OR ’diethylcarbamazine’)) OR ((’bithionol’/exp OR ’bithionol’) OR (’bithionol’/exp OR ’bithionol’)) OR ((’oxamniquine’/exp OR ’oxamniquine’) OR (’oxamniquine’/exp OR ’oxamniquine’)) OR ((’pyrantel’/exp OR ’pyrantel’) OR (’pyrantel’/exp OR ’pyrantel’)) OR ((’nitazoxanide’/exp OR ’nitazoxanide’) OR (’nitazoxanide’/exp OR ’nitazoxanide’)) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3 OR #4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #2 AND #5 [1‐1‐1980]/sd NOT [29‐09‐2015]/sd</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006419-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Search terms used in 2009 newly applied in CENTRAL</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(HIV INFECTIONS) OR HIV OR HIV OR HIV‐1* OR HIV‐2* OR HIV1 OR HIV2 OR (HIV INFECT*) OR (HUMAN IMMUNODEFICIENCY VIRUS) OR (HUMAN IMMUNEDEFICIENCY VIRUS) OR (HUMAN IMMUNO‐DEFICIENCY VIRUS) OR (HUMAN IMMUNE‐DEFICIENCY VIRUS) OR ((HUMAN IMMUN*) AND (DEFICIENCY VIRUS)) OR (ACQUIRED IMMUNODEFICIENCY SYNDROME) OR (ACQUIRED IMMUNEDEFICIENCY SYNDROME) OR (ACQUIRED IMMUNO‐DEFICIENCY SYNDROME) OR (ACQUIRED IMMUNE‐DEFICIENCY SYNDROME) OR ((ACQUIRED IMMUN*) AND (DEFICIENCY SYNDROME)) OR (VIRAL SEXUALLY TRANSMITTED DISEASES) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HELMINTHS OR ROUNDWORM OR ROUND WORM OR ROUND‐WORM OR ROUNDWORMS OR ROUND WORMS OR ROUND‐WORMS OR NEMATODES OR NEMATODE OR CESTODE OR CES‐TODES OR TAPEWORM OR TAPE WORM OR TAPE‐WORM OR TAPEWORMS OR TAPE WORMS OR TAPE‐WORMS OR TREMATODE OR TREMATODES OR FLUKE OR FLUKES OR WORM OR WORMS OR PARASITE OR PARASITES OR ASCARIS OR TRICHURIS OR ENTEROBIUS OR STRONGYLOIDE OR STRONGYLOIDES OR ANCYLOSTOMA OR ANCYLOSTOMAS OR NECATOR OR NECATORS OR HYMENOLEPIS OR PARAGONIMUS OR FASCIOLA OR TAENIA OR HOOKWORM OR HOOK WORM OR HOOK‐WORM OR HOOKWORMS OR HOOK WORMS OR HOOK‐WORMS OR WHIPWORM OR WHIP WORM OR WHIP‐WORM OR WHIPWORMS OR WHIP WORMS OR WHIP‐WORMS OR SCHISTOSOMIASIS OR MANSONELLA OR FILARIASIS OR MICROFILARIA OR TRICHOSTRONGYLUS OR TRICHOSTRONGYLOSIS OR STRONGYLOIDEA OR PARAGONIMIASIS </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BENZIMIDAZOLES OR ALBENDAZOLE OR MEBENDAZOLE OR IVERMECTIN OR PRAZIQUANTEL OR DIETHYLCARBAMAZINE OR BITHIONOL OR OXAMNIQUINE OR PYRANTEL OR NITAZOXANIDE </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2 OR #3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #4 from 1980 to 2015</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006419-tbl-0012"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Search terms used in 2009 newly applied in AIDSEARCH</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(HIV INFECTIONS) OR HIV OR HIV OR HIV‐1* OR HIV‐2* OR HIV1 OR HIV2 OR (HIV INFECT*) OR (HUMAN IMMUNODEFICIENCY VIRUS) OR (HUMAN IMMUNEDEFICIENCY VIRUS) OR (HUMAN IMMUNO‐DEFICIENCY VIRUS) OR (HUMAN IMMUNE‐DEFICIENCY VIRUS) OR ((HUMAN IMMUN*) AND (DEFICIENCY VIRUS)) OR (ACQUIRED IMMUNODEFICIENCY SYNDROME) OR (ACQUIRED IMMUNEDEFICIENCY SYNDROME) OR (ACQUIRED IMMUNO‐DEFICIENCY SYNDROME) OR (ACQUIRED IMMUNE‐DEFICIENCY SYNDROME) OR ((ACQUIRED IMMUN*) AND (DEFICIENCY SYNDROME)) OR (SEXUALLY TRANSMITTED DISEASES, VIRAL) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>((RANDOMIZED CONTROLLED TRIAL) OR (CONTROLLED CLINICAL TRIAL) OR (RANDOMIZED CONTROLLED TRIALS) OR (RANDOM ALLOCATION) OR (DOUBLE‐BLIND METHOD) OR (SINGLE‐ BLIND METHOD) OR (CLINICAL TRIAL) OR (CLINICAL TRIALS) OR (“CLINICAL TRIAL”) OR ((SINGL* OR DOUBL* OR TREBL* OR TRIPL* AND (MASK* OR BLIND*)) OR PLACEBOS OR PLACEBO* OR RANDOM* OR (COMPARATIVE STUDY) OR (EVALUATION STUDIES) OR (FOLLOW‐UP STUDIES) OR (PROSPECTIVE STUDIES) OR CONTROL* OR PROSPECTIV* OR VOLUNTEER*)) NOT (ANIMALS NOT HUMAN) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HELMINTHS OR ROUNDWORM OR ROUND WORM OR ROUND‐WORM OR ROUNDWORMS OR ROUND WORMS OR ROUND‐WORMS OR NEMATODES OR NEMATODE OR CESTODE OR CES‐TODES OR TAPEWORM OR TAPE WORM OR TAPE‐WORM OR TAPEWORMS OR TAPE WORMS OR TAPE‐WORMS OR TREMATODE OR TREMATODES OR FLUKE OR FLUKES OR WORM OR WORMS OR PARASITE OR PARASITES OR ASCARIS OR TRICHURIS OR ENTEROBIUS OR STRONGYLOIDE OR STRONGYLOIDES OR ANCYLOSTOMA OR ANCYLOSTOMAS OR NECATOR OR NECATORS </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HYMENOLEPIS OR PARAGONIMUS OR FASCIOLA OR TAENIA OR HOOKWORM OR HOOK WORM OR HOOK‐WORM OR HOOKWORMS OR HOOK WORMS OR HOOK‐WORMS OR WHIPWORM OR WHIP WORM OR WHIP‐WORM OR WHIPWORMS OR WHIP WORMS OR WHIP‐WORMS OR SCHISTOSOMIASIS OR MANSONELLA OR FILARIASIS OR MICROFILARIA OR TRICHOSTRONGYLUS OR TRICHOSTRONGYLOSIS OR STRONGYLOIDEA OR PARAGONIMIASIS </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BENZIMIDAZOLES OR ALBENDAZOLE OR MEBENDAZOLE OR IVERMECTIN OR PRAZIQUANTEL OR DIETHYLCARBAMAZINE OR BITHIONOL OR OXAMNIQUINE OR PYRANTEL OR NITAZOXANIDE </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4 OR #5 OR #6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#7 AND #3</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006419-tbl-0013"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Search strategy for the WHO Global Health Library</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Helminth* AND "HIV Infections" received from 01/01/1980 to 09/29/2015</p> </td> </tr> </tbody> </table> </div> <p>We did not apply any language or date restrictions.</p> </section> <section id="CD006419-sec-0042"> <h4 class="title">Searching other resources</h4> <section id="CD006419-sec-0043"> <h5 class="title">Reference lists</h5> <p>We examined all references cited by included trials to identify any further studies for inclusion. </p> </section> </section> </section> <section id="CD006419-sec-0044"> <h3 class="title" id="CD006419-sec-0044">Data collection and analysis</h3> <section id="CD006419-sec-0045"> <h4 class="title">Selection of studies</h4> <p>Two review authors (ARM and PB) independently read the titles, abstracts, and descriptor terms of all downloaded material from the electronic searches and discarded any irrelevant reports. When there was uncertainty as to the relevance of the study, we maintained the citation for further review. Two review authors (ARM and PB) then independently evaluated the full‐text articles of all identified citations to establish relevance of the article according to the pre‐specified criteria. </p> <p>We reviewed the studies for relevance based on study design, types of participants, exposures, and outcome measures. ARM and PB independently applied the inclusion criteria for this Cochrane Review update. There were three differences that required a third review author (JW) to resolve. </p> </section> <section id="CD006419-sec-0046"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (ARM and PB) independently extracted data from the included trials using standardized data extraction forms for randomized trials, as detailed in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006419-bbs2-0055" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>We extracted the following characteristics from each included trial.</p> <p> <ul id="CD006419-list-0004"> <li> <p>Administrative details: identification; author(s); published or unpublished; year of publication; year in which study was conducted; funding source. </p> </li> <li> <p>Details of study: study design; randomization method; duration; completeness of follow‐up; country and location of the study; setting (for example, urban or rural, hospital or clinic); method(s) of recruitment; number of participants by trial arm. </p> </li> <li> <p>Characteristics of participants: age; gender; socioeconomic status; HIV clinical staging (if available); antiretroviral (ART) status. </p> </li> <li> <p>Details of intervention: medication; dose; duration; number of treatments; control group. </p> </li> <li> <p>Details of outcomes: primary outcome; unit of measurement; change in viral load; change in CD4+ count; change in rate of clinical HIV disease progression (changes in the WHO or Centers for Disease Control and Prevention (CDC) staging); nutritional indicators; adverse events; mortality. </p> </li> </ul> </p> </section> <section id="CD006419-sec-0047"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (ARM and PB) independently evaluated the methodological quality of included clinical trials using the Cochrane 'Risk of bias' assessment tool described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006419-bbs2-0055" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>We followed the guidance to assess whether adequate steps were taken to reduce the risk of bias across five domains: sequence generation; allocation concealment; blinding of participants and personnel; blinding of outcome assessors; and incomplete outcome data. </p> <p>For sequence generation and allocation concealment, we reported the methods used. For blinding, we described who was blinded and the blinding method. For incomplete outcome data, we reported the percentage and proportion of participants lost to follow‐up. We categorized our 'Risk of bias' judgements as either 'low', 'high', or 'unclear'. Where risk of bias was unclear, we attempted to contact the trial authors for clarification and resolved any differences of opinion through discussion. </p> </section> <section id="CD006419-sec-0048"> <h4 class="title">Measures of treatment effect</h4> <p>We summarized dichotomous outcomes using risk ratios (RR) with 95% confidence interval (CIs). We summarized continuous outcomes using mean differences with 95% CIs. For some studies we utilized only data from HIV‐positive participants and the trial authors provided the raw data accordingly. </p> <p>HIV disease progression is associated with a decline in CD4+ cell counts and an increase in viral load. A favourable effect of deworming drugs on CD4+ cell count therefore refers to either a larger increase in CD4+ cell count or a smaller depletion in CD4+ cell count. A suppressive effect on viral load refers to either a reduction in viral load, or a smaller increase in viral load. </p> </section> <section id="CD006419-sec-0049"> <h4 class="title">Unit of analysis issues</h4> <p>For trials with repeat outcome measurements over time, we utilized and reported the study's final outcome measure reflecting the whole follow‐up time for each individual participant. For studies with 2 x 2 factorial designs in which there were more than one treatment group we chose not to combine experimental intervention groups into a single group and risk loss of information regarding the effects of different antihelminthic treatments. Rather, we chose to present the interventions separately and divide the total number of participants in the control group to account for multiple comparisons in meta‐analyses. The means and standard deviations were left unchanged as recommended in Section 16.5.4 of the Cochrane Handbook (<a href="./references#CD006419-bbs2-0055" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). This method only partially overcomes the unit‐of‐analysis error (because the resulting comparisons remain correlated). However, an advantage of this approach is that it allows for investigations of heterogeneity across intervention arms. </p> </section> <section id="CD006419-sec-0050"> <h4 class="title">Dealing with missing data</h4> <p>We contacted trial authors where there were missing or unclear data. We considered missing data resulting from losses to follow‐up to be missing at random unless there were indications otherwise. </p> </section> <section id="CD006419-sec-0051"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity amongst trials by inspecting the forest plots (to detect overlapping CIs) and the I² statistic with a level of 50% to denote moderate levels of heterogeneity, as well as by applying the Chi² test with a P value of 0.10 to indicate statistical significance, as described in Section 9.5.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006419-bbs2-0055" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD006419-sec-0052"> <h4 class="title">Assessment of reporting biases</h4> <p>We could not perform an assessment of the likelihood of reporting bias due to an insufficient number of included trials. </p> </section> <section id="CD006419-sec-0053"> <h4 class="title">Data synthesis</h4> <p>We pooled the results from included RCTs in six different meta‐analyses, using a random‐effects method, due to the heterogeneity of the interventions (<a href="./references#CD006419-bbs2-0049" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐89. ">DerSimonian 1986</a>). We performed pooled meta‐analyses to assess the outcomes of change in mean plasma viral load in populations with unknown helminth infection status, change in mean CD4+ cell count in populations with unknown helminth infection status, change in mean plasma viral load in helminth‐infected populations only, change in mean CD4+ cell count in helminth‐infected populations only, difference in adverse events, and difference in mortality events. </p> <p>We assessed the quality of evidence by outcome using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. We used GRADEprofiler Guideline Development Tool (GDT) software (<a href="./references#CD006419-bbs2-0053" title="GRADEpro GDT: GRADEpro Guideline Development Tool [Software] McMaster University, 2015 (developed by Evidence Prime, Inc.). Available from www.gradepro.org. ">GRADEpro GDT 2015</a>) to import data from Review Manager (RevMan) (<a href="./references#CD006419-bbs2-0066" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) to create three 'Summary of findings' tables. For each of the review outcomes we created a summary of the intervention effect and a measure of quality using the GRADE approach whereby the quality of evidence received a grade of either 'very low', 'low', 'moderate', or 'high', by outcome. We assessed the quality of the evidence based on five criteria: risk of bias, imprecision, indirectness, inconsistency, and publication bias. </p> </section> <section id="CD006419-sec-0054"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We conducted subgroup analyses with respect to trials in which participants had confirmed helminth infections, as well as trials in which participants had unknown infection status. We planned to investigate statistical heterogeneity by conducting subgroup analysis with respect to antihelminthic treatment used, participant age, ARV initiation status, and geographic location. However, we could not do so because of the limited number of studies included for meta‐analyses. </p> </section> <section id="CD006419-sec-0055"> <h4 class="title">Sensitivity analysis</h4> <p>We assessed the robustness of the results by conducting a sensitivity analysis against the 'Risk of bias' criteria. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006419-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006419-sec-0056"></div> <section id="CD006419-sec-0057"> <h3 class="title">Description of studies</h3> <section id="CD006419-sec-0058"> <h4 class="title">Results of the search</h4> <p>In this Cochrane Review update, we identified 312 references using the CIDG Information Specialist's search criteria described above and an additional 1936 unique references by applying the search criteria utilized in the 2009 Cochrane Review (<a href="./references#CD006419-bbs2-0078" title="WalsonJL , HerrinBR , John‐StewartG . Deworming helminth co‐infected individuals for delaying HIV disease progression. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD006419.pub3] ">Walson 2009</a>). Of the 2248 citations screened, we excluded 2203 citations due to irrelevance to antihelminthics, no inclusion of HIV‐positive participants, or both. We retrieved and formally reviewed 42 full‐text articles for eligibility (see <a href="#CD006419-fig-0001">Figure 1</a> for the study flow diagram). </p> <div class="figure" id="CD006419-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006419-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD006419-sec-0059"> <h4 class="title">Included studies</h4> <p>Eight randomized controlled trials (RCTs) met the inclusion criteria of this Cochrane Review. Three were included in the 2009 version of this Cochrane Review (<a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>; <a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a>; <a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a>) and we added five new trials, due to more recent publication dates or the expanded scope of the protocol (<a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. ">Abate 2014 ETH</a>; <a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a>; <a href="./references#CD006419-bbs2-0005" title="SuputtamongkolY , PremasathianN , BhumimuangK , WaywaD , NilganuwongS , KaruphongE , et al. Efficacy and safety of single and double doses of ivermectin versus 7‐day high dose albendazole for chronic strongyloidiasis. PLoS Neglected Tropical Diseases2011;5(5):e1044. ">Suputtamongkol 2011 THA</a>; <a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a>; <a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a>). </p> <p>Seven trials were conducted in sub‐Saharan Africa, and one in Thailand (<a href="./references#CD006419-bbs2-0005" title="SuputtamongkolY , PremasathianN , BhumimuangK , WaywaD , NilganuwongS , KaruphongE , et al. Efficacy and safety of single and double doses of ivermectin versus 7‐day high dose albendazole for chronic strongyloidiasis. PLoS Neglected Tropical Diseases2011;5(5):e1044. ">Suputtamongkol 2011 THA</a>). All eight trials included adults infected with HIV‐1 or HIV‐2, and one trial was limited to pregnant adult women (<a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a>). One small trial from Zambia recruited only adults with chronic diarrhoea (<a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a>). There were no trials in preschool or school‐age children. </p> <p>The RCTs aimed to evaluate a range of primary outcomes: changes in tuberculosis (TB) morbidity factors (<a href="https://archie.cochrane.org/sections/documents/view?version=z1508271507343839098977151848098%26format=REVMAN#STD-Abate-2014-ETH" target="_blank">Abate 2014 ETH</a>), diarrhoea duration (<a href="https://archie.cochrane.org/sections/documents/view?version=z1508271507343839098977151848098%26format=REVMAN#STD-Kelly-1996-ZMB" target="_blank">Kelly 1996 ZMB</a>), clearance of <i>Strongyloides</i> infection (<a href="https://archie.cochrane.org/sections/documents/view?version=z1508271507343839098977151848098%26format=REVMAN#STD-Suputtamongkol-2011-THA" target="_blank">Suputtamongkol 2011 THA</a>), CD4+/CD8+ cell ratios (<a href="https://archie.cochrane.org/sections/documents/view?version=z1508271507343839098977151848098%26format=REVMAN#STD-Nielsen-2007-TZA" target="_blank">Nielsen 2007 TZA</a>), CD4+ cell count (<a href="https://archie.cochrane.org/sections/documents/view?version=z1508271507343839098977151848098%26format=REVMAN#STD-Kallestrup-2005-ZWE" target="_blank">Kallestrup 2005 ZWE</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1508271507343839098977151848098%26format=REVMAN#STD-Nielsen-2007-TZA" target="_blank">Nielsen 2007 TZA</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1508271507343839098977151848098%26format=REVMAN#STD-Walson-2008-KEN" target="_blank">Walson 2008 KEN</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1508271507343839098977151848098%26format=REVMAN#STD-Walson-2012-KEN" target="_blank">Walson 2012 KEN</a>), and HIV‐1 RNA viral load (<a href="https://archie.cochrane.org/sections/documents/view?version=z1508271507343839098977151848098%26format=REVMAN#STD-Kallestrup-2005-ZWE" target="_blank">Kallestrup 2005 ZWE</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1508271507343839098977151848098%26format=REVMAN#STD-Nielsen-2007-TZA" target="_blank">Nielsen 2007 TZA</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1508271507343839098977151848098%26format=REVMAN#STD-Walson-2008-KEN" target="_blank">Walson 2008 KEN</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1508271507343839098977151848098%26format=REVMAN#STD-Walson-2012-KEN" target="_blank">Walson 2012 KEN</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1508271507343839098977151848098%26format=REVMAN#STD-Webb-2012-UGA" target="_blank">Webb 2012 UGA</a>). </p> <p>In two trials, HIV‐positive participants were not taking antiretroviral (ART) drugs (<a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a>; <a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a>), in one trial ART use was limited to prevention of mother‐to‐child transmission of HIV (<a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a>), and in one trial ART use was very high (<a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. ">Abate 2014 ETH</a>). Four trials did not specify if the HIV‐positive individuals were currently taking ART (<a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>; <a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a>; <a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a>; <a href="./references#CD006419-bbs2-0005" title="SuputtamongkolY , PremasathianN , BhumimuangK , WaywaD , NilganuwongS , KaruphongE , et al. Efficacy and safety of single and double doses of ivermectin versus 7‐day high dose albendazole for chronic strongyloidiasis. PLoS Neglected Tropical Diseases2011;5(5):e1044. ">Suputtamongkol 2011 THA</a>). </p> <p>Three trials evaluated deworming drugs provided presumptively to participants with unknown helminth infection status: <a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a> administered albendazole (400 mg) every three months and praziquantel (40 mg/kg) annually for two years; <a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a> administered either albendazole (800 mg), praziquantel (40 mg/kg), or both to pregnant women and followed up for six weeks and at delivery; and <a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a> administered albendazole (800 mg) twice daily for two weeks to adults with chronic diarrhoea (see <a href="#CD006419-tbl-0014">Table 11</a> and <a href="#CD006419-tbl-0015">Table 12</a>). </p> <div class="table" id="CD006419-tbl-0014"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Characteristics of trials in which participants had unknown helminth infection status</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Year enrolment completed</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Inclusion criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total randomized</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number HIV‐positive participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Taking ART</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number co‐infected with helminths at baseline</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zambia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urban</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected adults with persistent diarrhoea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated (probably low)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uganda</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urban</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected pregnant women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67% had at least 1 helminth species</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenya</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urban/rural</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected, not on ART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>948</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>948</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None at baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>Abbreviations</b>: HIV: human immunodeficiency virus; ART: antiretroviral. </p> </div> </div> <div class="table" id="CD006419-tbl-0015"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 12.</span> <span class="table-title">Description of interventions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Timing</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Drug</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Albendazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once daily for 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Viral load</p> <p>CD4</p> <p>Adverse events</p> <p>Mortality events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. ">Abate 2014 ETH</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Albendazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once daily for 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CD4</p> <p>Adverse events</p> <p>Mortality events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Praziquantel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Viral load</p> <p>CD4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diethylcarbamazine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Viral load</p> <p>CD4</p> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Albendazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice daily for 14 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> <p>Mortality events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0005" title="SuputtamongkolY , PremasathianN , BhumimuangK , WaywaD , NilganuwongS , KaruphongE , et al. Efficacy and safety of single and double doses of ivermectin versus 7‐day high dose albendazole for chronic strongyloidiasis. PLoS Neglected Tropical Diseases2011;5(5):e1044. ">Suputtamongkol 2011 THA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ivermectin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single or double dose 2 weeks apart</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Albendazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 year</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Albendazole</p> <p>Praziquantel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 mg</p> <p>40 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once only</p> <p>Once only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Viral load</p> <p>Adverse events</p> <p>Mortality events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Albendazole</p> <p>Praziquantel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 mg</p> <p>25 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Every 3 months</p> <p>Annually</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Viral load</p> <p>CD4</p> <p>Adverse events</p> <p>Mortality events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 years</p> </td> </tr> </tbody> </table> </div> <p>Five RCTs treated HIV‐positive adults with confirmed helminth infections; two trials treated soil‐transmitted helminth (STH) infections with albendazole (400 mg) once daily for three days (<a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. ">Abate 2014 ETH</a>; <a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a>), one study treated schistosomiasis with praziquantel (40 mg/kg) once only (<a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>), one study treated STH or schistosomiasis with albendazole, praziquantel, or both (<a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a>), and one trial treated lymphatic filariasis (LF) with diethylcarbamazine (DEC) (<a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a>). These trials followed participants for six to 12 weeks (see <a href="#CD006419-tbl-0016">Table 13</a> and <a href="#CD006419-tbl-0015">Table 12</a>). </p> <div class="table" id="CD006419-tbl-0016"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 13.</span> <span class="table-title">Characteristics of trials in which participants had confirmed helminth infections</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Year enrolment completed</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Inclusion criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total randomized</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of HIV‐positive participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Taking ART</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number co‐infected with helminths at baseline</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. "><b>Walson 2008 KEN</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenya</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urban/rural</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected with at least one helminth co‐infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None at baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. "><b>Abate 2014 ETH</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ethiopia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urban</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Newly diagnosed TB participants with helminth co‐infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 to 60 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94% of intervention group, 100% of controls</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. "><b>Kallestrup 2005 ZWE</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zimbabwe</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rural</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults infected with schistosomiasis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. "><b>Nielsen 2007 TZA</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tanzania</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rural</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22 to 70 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0005" title="SuputtamongkolY , PremasathianN , BhumimuangK , WaywaD , NilganuwongS , KaruphongE , et al. Efficacy and safety of single and double doses of ivermectin versus 7‐day high dose albendazole for chronic strongyloidiasis. PLoS Neglected Tropical Diseases2011;5(5):e1044. "><b>Suputtamongkol 2011 THA</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thailand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urban</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults with characteristic strongyloides infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>Abbreviations:</b> HIV: human immunodeficiency virus; ART: antiretroviral; TB: tuberculosis. </p> </div> </div> <p>Five trials measured and reported HIV‐1 RNA viral load (<a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>; <a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a>; <a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a>; <a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a>; <a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a>), and four trials reported CD4+ cell count (<a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>; <a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a>; <a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a>; <a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a>). One study reported CD4+/CD8+ cell ratio, seven trials reported adverse events, one trial reported measures of iron deficiency and anaemia respectively, and six trials reported mortality. </p> <p>We requested unpublished data from all but one trial author (<a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a>), and we included these data in the analyses. </p> </section> <section id="CD006419-sec-0060"> <h4 class="title">Excluded studies</h4> <p>We excluded 33 studies due to their observational designs or irrelevance to the intervention or outcomes of interest. See the '<a href="./references#CD006419-sec-0100" title="">Characteristics of excluded studies</a>' table. We identified two ongoing or planned RCTs, and have provided descriptions of these trials in <a href="#CD006419-tbl-0017">Table 14</a>. </p> <div class="table" id="CD006419-tbl-0017"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 14.</span> <span class="table-title">Ongoing or planned RCTs</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial name</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relevant intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relevant outcome</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Target population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Location(s)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Estimated completion date</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reduction of EArly mortaLITY in HIV‐infected Adults and Children Starting Antiretroviral Therapy (REALITY) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Immediate enhanced opportunistic infections (OI) prophylaxis with isoniazid/pyridoxine and cotrimoxazole, plus 12 weeks fluconazole, 5 days azithromycin, and a single dose of albendazole versus cotrimoxazole prophylaxis alone for the first 12 weeks followed by isoniazid and any prophylaxis and/or treatment prescribed at screening </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>• Change in CD4 count</p> <p>• Adverse events</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected individuals ages ≥ 5 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenya, Malawi, Uganda, Zimbabwe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>February 2016</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Can Anthelminthic Treatment Delay the Progression of HIV? Randomised Open‐label Trial Testing Presumptive Anthelminthic Treatment on Progression of HIV in ART‐naïve HIV‐positive Patients in a Rural African Setting With Presumed High Prevalence of Helminth Infections </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard HIV care with provision of praziquantel, albendazole, and ivermectin at baseline, after 6 months, and after 12 months versus standard HIV care with no anthelminthic treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>• Change in viral load</p> <p>• Change in CD4 count</p> <p>• Adverse event</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected individuals aged ≥ 18 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tanzania</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Terminated prematurely due to recruitment difficulties</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>Abbreviations:</b> RCT: randomized controlled trial; HIV: human immunodeficiency virus; ART: antiretroviral. </p> </div> </div> </section> </section> <section id="CD006419-sec-0061"> <h3 class="title">Risk of bias in included studies</h3> <p>We have presented a summary of our 'Risk of bias' assessments in <a href="#CD006419-fig-0002">Figure 2</a> and <a href="#CD006419-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD006419-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included trial." data-id="CD006419-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included trial. </p> </div> </div> </div> <div class="figure" id="CD006419-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included trials." data-id="CD006419-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included trials. </p> </div> </div> </div> <section id="CD006419-sec-0062"> <h4 class="title">Allocation</h4> <p>Five trials adequately described both random sequence generation and allocation concealment and we judged them at low risk of selection bias (<a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. ">Abate 2014 ETH</a>; <a href="./references#CD006419-bbs2-0005" title="SuputtamongkolY , PremasathianN , BhumimuangK , WaywaD , NilganuwongS , KaruphongE , et al. Efficacy and safety of single and double doses of ivermectin versus 7‐day high dose albendazole for chronic strongyloidiasis. PLoS Neglected Tropical Diseases2011;5(5):e1044. ">Suputtamongkol 2011 THA</a>; <a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a>; <a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a>; <a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a>). One trial did not describe allocation concealment and was at unclear risk of selection bias (<a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a>), and one stated that allocation was 'open' and was at high risk of selection bias (<a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>). All included trials appeared to have similar reported baseline characteristics between randomization groups. </p> </section> <section id="CD006419-sec-0063"> <h4 class="title">Blinding</h4> <p>Five trials used placebos and we judged them to be at low risk of performance bias (systematic differences between groups in the care that is provided, or in exposure to factors other than the interventions of interest) (<a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. ">Abate 2014 ETH</a>; <a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a>; <a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a>; <a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a>; <a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a>). We judged the remaining trials to be at high risk of performance bias (<a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>; <a href="./references#CD006419-bbs2-0005" title="SuputtamongkolY , PremasathianN , BhumimuangK , WaywaD , NilganuwongS , KaruphongE , et al. Efficacy and safety of single and double doses of ivermectin versus 7‐day high dose albendazole for chronic strongyloidiasis. PLoS Neglected Tropical Diseases2011;5(5):e1044. ">Suputtamongkol 2011 THA</a>; <a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a>). In addition, individual participants who received more frequent treatment doses had more opportunities to interface with health facilities as an inherent aspect of the intended trial design and may have non‐differentially had access to improved care. </p> <p>Only two trials adequately described blinding of outcomes assessment to prevent detection bias (<a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. ">Abate 2014 ETH</a>; <a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>). The remaining trials were at unclear risk of bias. Two trials utilized diagnostic methods with low sensitivity, such as duplicate Kato‐Katz from a single stool sample (<a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a>; <a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a>), which might affect the total sample size of helminth‐infected participants, but not the fidelity of the intervention or outcome measures. </p> </section> <section id="CD006419-sec-0064"> <h4 class="title">Incomplete outcome data</h4> <p>Attrition bias may have been an issue in one included trial, <a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a>, where there appeared to be differential loss to follow‐up between the groups. In addition, two trials reported that less than 80% of the established participant cohort were followed‐up (<a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>; <a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a>), although <a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a> reported that reasons for study drop‐out were evenly distributed, with the exception of a single group which had a higher number of losses to follow‐up due to migration. </p> </section> <section id="CD006419-sec-0065"> <h4 class="title">Selective reporting</h4> <p>We could not perform an assessment of the likelihood of reporting bias due to an insufficient number of included trials. </p> <p>Five trials performed and reported an intention‐to‐treat analysis (<a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. ">Abate 2014 ETH</a>; <a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>; <a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a>; <a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a>; <a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a>). The three remaining trials performed outcome comparisons only for participants for whom follow‐up data were available or relevant (<a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a>; <a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a>; <a href="./references#CD006419-bbs2-0005" title="SuputtamongkolY , PremasathianN , BhumimuangK , WaywaD , NilganuwongS , KaruphongE , et al. Efficacy and safety of single and double doses of ivermectin versus 7‐day high dose albendazole for chronic strongyloidiasis. PLoS Neglected Tropical Diseases2011;5(5):e1044. ">Suputtamongkol 2011 THA</a>). </p> </section> </section> <section id="CD006419-sec-0066"> <h3 class="title" id="CD006419-sec-0066">Effects of interventions</h3> <p>See: <a href="./full#CD006419-tbl-0001"><b>Summary of findings for the main comparison</b> Summary of findings for participants with unknown helminth infection status</a>; <a href="./full#CD006419-tbl-0002"><b>Summary of findings 2</b> Summary of findings for participants with confirmed helminth infections</a>; <a href="./full#CD006419-tbl-0003"><b>Summary of findings 3</b> Summary of findings for secondary outcomes</a> </p> <section id="CD006419-sec-0067"> <h4 class="title">Comparison: antihelminthic drugs versus placebo or no intervention</h4> <section id="CD006419-sec-0068"> <h5 class="title">Primary outcomes: markers of HIV disease progression</h5> <section id="CD006419-sec-0069"> <h6 class="title">Participants with unknown helminth infection status</h6> <p>Two trials evaluated the effects of antihelminthic drugs versus placebo on HIV disease progression amongst HIV‐positive adults in sub‐Saharan Africa with unknown helminth infection status. One trial administered either albendazole (800 mg), praziquantel (40 mg/kg), or both, to pregnant women and followed up for six weeks (<a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a>), and one administered albendazole (400 mg) every three months and praziquantel (40 mg/kg) annually for two years (<a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a>). </p> <section id="CD006419-sec-0070"> <p><b>Viral load</b></p> <p>In the single included trial of pregnant women, the mean viral load at six weeks was lower with each of the interventions, but the confidence intervals (CIs) included the possibility of no difference (difference in mean change −0.14 log<sub>10</sub> viral RNA, 95% CI −0.35 to 0.07; P = 0.19, one trial, 166 participants, <a href="./references#CD006419-fig-0004" title="">Analysis 1.1</a>). </p> <p>In the larger trial from Kenya, there was no substantial difference in mean change in viral load between treatment and control groups after two years of repeated drug administration (difference in mean change 0.01 log<sub>10</sub> viral RNA, 95% CI −0.03 to 0.05; P = 0.66, one trial, 917 participants, <a href="./references#CD006419-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD006419-sec-0071"> <p><b>CD4+ cell count</b></p> <p>Only the long‐term trial from Kenya reported mean change in CD4+ cell counts. There was no substantial difference in mean change in CD4+ count between the treatment and control groups over two years of repeated drug administration (difference in mean change 2.60 cells/µL/year, 95% CI −10.15 to 15.35; P = 0.7, one trial, 917 participants, <a href="./references#CD006419-fig-0005" title="">Analysis 1.2</a>). </p> </section> </section> <section id="CD006419-sec-0072"> <h6 class="title">Participants with confirmed helminth infections</h6> <p>Five trials treated HIV‐positive adults known to be infected with helminths; two trials treated STH infection with albendazole (400 mg) once daily for three days (<a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. ">Abate 2014 ETH</a>; <a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a>), one trial treated schistosomiasis with praziquantel (40 mg/kg) once only (<a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>), and one trial treated LF with DEC (<a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a>). These trials reported these outcomes at 12 weeks. One trial also provided outcome data at six weeks for participants infected with schistosomiasis and STHs (<a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a>). </p> <section id="CD006419-sec-0073"> <p><b>Viral load</b></p> <p>In a pooled analysis across four trials with different helminth infections and different drug regimens, there was an overall suppressive effect on viral load after six to 12 weeks in the intervention groups compared to controls (difference in mean change −0.13 log<sub>10</sub> viral RNA, 95% CI −0.26 to −0.00; P = 0.04, four trials, 445 participants, <a href="./references#CD006419-fig-0006" title="">Analysis 2.1</a>). However the CIs of the individual trials are wide and the CIs of all but one trial, <a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>, included the possibility of no effect. In this trial of HIV and schistosomiasis co‐infected participants, those treated with praziquantel had little change in mean plasma viral load at 12 weeks (−0.001 log<sub>10</sub> viral RNA), while the mean viral load substantially increased in the untreated group (0.21 log<sub>10</sub> viral RNA, P = 0.03). This trial was at high risk of selection bias, and exclusion of this trial broadens the CI of the pooled estimate to allow the possibility of no difference. </p> </section> <section id="CD006419-sec-0074"> <p><b>CD4+ cell count</b></p> <p>In three trials mean CD4+ cell count declined in both treated and control groups over 12 weeks, with a smaller decrease in the treated groups (<a href="./references#CD006419-fig-0007" title="">Analysis 2.2</a>). However in one trial of TB‐infected individuals who initiated both TB treatment and ART at baseline, CD4+ cell counts increased in both treated and control groups with a larger increase in those treated with deworming drugs (difference in mean change 43.00 cells/µL, 95% CI 1.14 to 84.86; one trial, 208 participants). In the pooled analysis, the average change in CD4+ cell count was more favourable in the group treated with deworming drugs, and the CI excludes the possibility of no effect (difference in mean change 37.86 cells/µL, 95% CI 7.36 to 68.35; P = 0.01; three trials, 358 participants, <a href="./references#CD006419-fig-0007" title="">Analysis 2.2</a>). </p> <p><a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a> presented results as declines in CD4+ per cent, and thus we did not include the results in the pooled meta‐analysis (<a href="./references#CD006419-fig-0007" title="">Analysis 2.2</a>). </p> </section> </section> </section> <section id="CD006419-sec-0075"> <h5 class="title">Secondary outcomes</h5> <section id="CD006419-sec-0076"> <h6 class="title">Adverse events</h6> <p>Seven trials commented on adverse events, of which five reported that no adverse events occurred (<a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. ">Abate 2014 ETH</a>; <a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a>; <a href="./references#CD006419-bbs2-0005" title="SuputtamongkolY , PremasathianN , BhumimuangK , WaywaD , NilganuwongS , KaruphongE , et al. Efficacy and safety of single and double doses of ivermectin versus 7‐day high dose albendazole for chronic strongyloidiasis. PLoS Neglected Tropical Diseases2011;5(5):e1044. ">Suputtamongkol 2011 THA</a>; <a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a>; <a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a>). </p> <p><a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a> administered albendazole twice daily for two weeks to adults with chronic diarrhoea, and reported seven adverse events in the treatment group and three in the control group. Of the seven adverse events with albendazole, one participant had a cutaneous reaction that resolved within one week of discontinuing the drug, and four complained of dizziness, headache, cough, and difficulty swallowing. The trial authors noted that the symptoms were indistinguishable from symptoms of the underlying illness. <a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a> administered praziquantel annually and albendazole every three months for two years, and reported 16 severe adverse events in the treatment group and 18 in the control group. The trial authors determined that none of the adverse events were directly related to the study drug. </p> <p>The pooled analysis of these two trials does not suggest a significant increase in relative risk for adverse events in HIV‐positive individuals who receive antihelminthics relative to those who do not (RR 1.23, 95% CI 0.53 to 2.83; P = 0.63, seven trials, 1649 participants, <a href="./references#CD006419-fig-0009" title="">Analysis 3.2</a>). </p> </section> <section id="CD006419-sec-0077"> <h6 class="title">Mortality</h6> <p>Six included trials recorded mortality events, of which five trials observed at least one death (<a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. ">Abate 2014 ETH</a>; <a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a>; <a href="./references#CD006419-bbs2-0005" title="SuputtamongkolY , PremasathianN , BhumimuangK , WaywaD , NilganuwongS , KaruphongE , et al. Efficacy and safety of single and double doses of ivermectin versus 7‐day high dose albendazole for chronic strongyloidiasis. PLoS Neglected Tropical Diseases2011;5(5):e1044. ">Suputtamongkol 2011 THA</a>; <a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a>; <a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a>). In the pooled analysis, treatment was associated with a point estimate of a 33% reduction in mortality, but the CIs included no effect (RR 0.77, 95% CI 0.52 to 1.14; P = 0.19, five trials, 1627 participants, <a href="./references#CD006419-fig-0010" title="">Analysis 3.3</a>). Most deaths occurred in the oldest study where participants were chronically unwell (had chronic diarrhoea) and were probably not on ART (<a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a>). None of the deaths appeared to be directly associated with the antihelminthic interventions, as reported by the trial authors. </p> </section> <section id="CD006419-sec-0078"> <h6 class="title">Anaemia and iron deficiency</h6> <p>Only one trial captured data regarding changes in serum haemoglobin levels (<a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>). The trial authors reported a mean difference in haemoglobin of −0.25 g/dL (95% CI −0.58 to −0.08) in the HIV‐positive participants that received praziquantel relative to the untreated participants over three months follow‐up (unpublished data). </p> <p>A secondary analysis of the primary <a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a> trial examined the effect of antihelminthic treatment on micronutrient indicators in LF and HIV co‐infected individuals (Nielsen 2009). The study found that serum ferritin levels increased in co‐infected individuals 12 weeks after treatment. The study authors observed a log mean increase of 0.07 µg/L in the treatment group, while they noted a log mean increase of 0.04 µg/L in the non‐treated group. The mean difference in log ferritin levels between baseline and 12 weeks follow‐up in the treated group relative to the control group was thus 0.03 µg/L (95% CI −0.30 to 0.35) (unpublished data provided by the study authors). As the study authors did not observe the same increase in ferritin in the HIV‐positive LF‐uninfected groups, the study authors hypothesize that the serum ferritin changes may be related to the immune mechanisms involved in killing of filaria. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006419-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006419-sec-0079"></div> <section id="CD006419-sec-0080"> <h3 class="title" id="CD006419-sec-0080">Summary of main results</h3> <p>In human immunodeficiency virus (HIV)‐infected antiretroviral (ART)‐naive adults with unknown helminth infection status, provision of deworming drugs (albendazole and praziquantel together or separately) may have a small suppressive effect on viral load at six weeks. However, these data come from a small single trial and the 95% confidence interval (CI) includes the possibility of no effect (<i>low quality evidence</i> ). Repeated dosing over two years appears to have little or no effect in HIV‐positive ART‐naive adults (<i>moderate quality evidence</i>). </p> <p>Treating helminth infections in HIV‐positive individuals with confirmed helminth infections may have a small suppressive effect on mean viral load at six to 12 weeks (<i>low quality evidence</i>). However, this finding is strongly influenced by a single study of praziquantel for schistosomiasis and further studies from different settings and populations are needed for validation. There may also be a small favourable effect on mean CD4+ cell count at 12 weeks. </p> <p>Most of the included trials did not consistently or rigorously report adverse events (<i>very low quality evidence)</i> and trials were underpowered to evaluate effects on mortality (<i>low quality evidence).</i> However, there is no indication of excessive risk associated with deworming HIV‐positive populations<i>.</i> </p> </section> <section id="CD006419-sec-0081"> <h3 class="title" id="CD006419-sec-0081">Overall completeness and applicability of evidence</h3> <p>Despite the publication of five new RCTs since the previous edition of this Cochrane Review, <a href="./references#CD006419-bbs2-0078" title="WalsonJL , HerrinBR , John‐StewartG . Deworming helminth co‐infected individuals for delaying HIV disease progression. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD006419.pub3] ">Walson 2009</a>, there is still insufficient evidence to make definitive conclusions about the effects of deworming drugs on markers of HIV disease progression. The eight trials included evaluate different drugs used to treat different helminth infections, which limits our ability to make broad generalizations. </p> <p>For preventive chemotherapy programmes, in which deworming drugs are provided presumptively to all individuals, this Cochrane Review includes only two relevant trials and only one that reported long‐term effects. In the short‐term trial there is a suggestion of a short‐term benefit to deworming, however the trial is too small to prove an effect. Similarly, while the single long‐term trial found no evidence of benefit, further trials from other settings with different helminth endemicities are necessary before the possibility of long‐term beneficial effects can be fully excluded. </p> <p>Only short‐term evidence is available when we limit the analysis to HIV‐positive adults with confirmed helminth infections. The finding of a suppressive effect on viral load in this group is highly reliant on a single trial of praziquantel for schistosomiasis. While the effect estimate of the pooled analysis is small (−0.13 log<sub>10</sub>), mathematical modelling exercises estimate that a decrease in viral load of 0.3 log<sub>10</sub> in heterosexual couples could decrease HIV transmission by an average of 20% and AIDS‐related illnesses or death by 25% (<a href="./references#CD006419-bbs2-0061" title="ModjarradK , ChamotE , VermundSH . Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS2008;22(16):2179‐85. ">Modjarrad 2008</a>). </p> <p>It is also important to note that none of the trials included children, and only one trial included a significant number of people taking ART (<a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. ">Abate 2014 ETH</a>). These are therefore important groups for further research. </p> <p>While overall few adverse events were reported in the included trials (23 in total in treated participants and 21 in total in non‐treated participants), it is important to note that only three trials defined adverse events, one with a detailed definition of qualifying adverse events (<a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a>), and two with more generalized definitions (<a href="./references#CD006419-bbs2-0005" title="SuputtamongkolY , PremasathianN , BhumimuangK , WaywaD , NilganuwongS , KaruphongE , et al. Efficacy and safety of single and double doses of ivermectin versus 7‐day high dose albendazole for chronic strongyloidiasis. PLoS Neglected Tropical Diseases2011;5(5):e1044. ">Suputtamongkol 2011 THA</a>; <a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a>). Only one trial reported how adverse events were monitored, using patient record‐keeping cards and house visits (<a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a>). Despite these biases, most randomized controlled trials (RCTs) reported no adverse events following antihelminthic therapy and there is no evidence of excessive harm associated with deworming in HIV‐positive populations. To validate review findings, larger RCTs should be conducted with well‐documented and active adverse event identification, as well as frequent follow‐up points to assess how deworming may affect HIV‐positive populations of all ages over time. </p> </section> <section id="CD006419-sec-0082"> <h3 class="title" id="CD006419-sec-0082">Quality of the evidence</h3> <p>We have presented the GRADE assessment of the quality of evidence in the included trials in the 'Summary of findings' tables (<a href="./full#CD006419-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD006419-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD006419-tbl-0003">summary of findings Table 3</a>)<i>.</i> The overall assessment of quality ranges from moderate (representing a moderate level of certainty in the result) to very low (where we are very uncertain of the result). </p> <p>The primary reason for downgrading the quality of evidence was 'indirectness', where we had too few trials to make broad generalizations about the potential effects. This is a particular problem for trials that evaluate deworming in populations with unknown helminth infection status as helminth endemicity varies substantially across settings, undoubtedly influencing observed findings. Although we had more data from trials that evaluated deworming drugs in participants with documented helminth infections, the substantial heterogeneity in populations and deworming drugs used again decreased our confidence in making broad generalizations. The second most common reason for downgrading the quality of evidence was 'imprecision' in effect estimates. Many of the included trials were small, and had wide 95% CIs, which included the possibility of both clinically important effects and no effect. </p> </section> <section id="CD006419-sec-0083"> <h3 class="title" id="CD006419-sec-0083">Potential biases in the review process</h3> <p>Judd Walson is a co‐author of this Cochrane Review and was Primary Investigator on two of the included RCTs. However, he was not involved in conducting any of the 'Risk of bias' assessments or in data extraction for this Cochrane Review. </p> <p>There were not enough trials available in the published literature to be able to assess for publication bias. </p> </section> <section id="CD006419-sec-0084"> <h3 class="title" id="CD006419-sec-0084">Agreements and disagreements with other studies or reviews</h3> <p>The first review on this topic, <a href="./references#CD006419-bbs2-0075" title="WalsonJL , John‐StewartG . Treatment of helminth co‐infection in individuals with HIV‐1: a systematic review of the literature. PLoS Neglected Tropical Diseases2007;1(3):e102. ">Walson 2007a</a>, identified only one RCT for inclusion that evaluated the potential benefit of treating helminth co‐infection in HIV‐1‐infected individuals (<a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a>). Subsequently two additional RCTs were published (<a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a>; <a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a>), and a Cochrane Review of all three RCTs concluded that treatment of helminth co‐infection appeared to result in favourable effects on markers of HIV‐1 disease progression (<a href="./references#CD006419-bbs2-0078" title="WalsonJL , HerrinBR , John‐StewartG . Deworming helminth co‐infected individuals for delaying HIV disease progression. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD006419.pub3] ">Walson 2009</a>). Specifically, the pooled analysis of the data suggested that treatment of helminth co‐infection may attenuate increases in HIV‐1 RNA and result in slower decline in CD4+ counts. </p> <p>The findings of this Cochrane Review update are consistent with the previous edition (<a href="./references#CD006419-bbs2-0078" title="WalsonJL , HerrinBR , John‐StewartG . Deworming helminth co‐infected individuals for delaying HIV disease progression. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD006419.pub3] ">Walson 2009</a>). However, we used the GRADE approach to assess the quality of evidence, which caused us to downgrade the quality of the evidence. As we stratified by helminth infection status, we also separately provide evidence for individuals who were helminth‐infected or of unknown infection status. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006419-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/urn:x-wiley:14651858:media:CD006419:CD006419-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_t/tCD006419-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006419-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006419-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/urn:x-wiley:14651858:media:CD006419:CD006419-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_t/tCD006419-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included trial." data-id="CD006419-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006419-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/urn:x-wiley:14651858:media:CD006419:CD006419-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_t/tCD006419-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included trials." data-id="CD006419-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included trials. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006419-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/urn:x-wiley:14651858:media:CD006419:CD006419-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_t/tCD006419-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Deworming drugs versus placebo in people with unknown helminth infection status, Outcome 1 Viral load: change in log10 HIV‐1 RNA." data-id="CD006419-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Deworming drugs versus placebo in people with unknown helminth infection status, Outcome 1 Viral load: change in log<sub>10</sub> HIV‐1 RNA. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/references#CD006419-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006419-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/urn:x-wiley:14651858:media:CD006419:CD006419-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_t/tCD006419-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Deworming drugs versus placebo in people with unknown helminth infection status, Outcome 2 Change in CD4 count." data-id="CD006419-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Deworming drugs versus placebo in people with unknown helminth infection status, Outcome 2 Change in CD4 count. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/references#CD006419-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006419-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/urn:x-wiley:14651858:media:CD006419:CD006419-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_t/tCD006419-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Deworming drugs versus placebo in people with confirmed helminth infection, Outcome 1 Viral load: change in log10 HIV‐1 RNA." data-id="CD006419-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Deworming drugs versus placebo in people with confirmed helminth infection, Outcome 1 Viral load: change in log<sub>10</sub> HIV‐1 RNA. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/references#CD006419-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006419-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/urn:x-wiley:14651858:media:CD006419:CD006419-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_t/tCD006419-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Deworming drugs versus placebo in people with confirmed helminth infection, Outcome 2 Change in CD4 count." data-id="CD006419-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Deworming drugs versus placebo in people with confirmed helminth infection, Outcome 2 Change in CD4 count. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/references#CD006419-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006419-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/urn:x-wiley:14651858:media:CD006419:CD006419-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_t/tCD006419-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Deworming drugs versus placebo; all trials, Outcome 1 Change in log10 HIV RNA, by antihelminthic." data-id="CD006419-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Deworming drugs versus placebo; all trials, Outcome 1 Change in log<sub>10</sub> HIV RNA, by antihelminthic. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/references#CD006419-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006419-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/urn:x-wiley:14651858:media:CD006419:CD006419-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_t/tCD006419-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Deworming drugs versus placebo; all trials, Outcome 2 Difference in adverse events between treatment and no treatment groups." data-id="CD006419-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Deworming drugs versus placebo; all trials, Outcome 2 Difference in adverse events between treatment and no treatment groups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/references#CD006419-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006419-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/urn:x-wiley:14651858:media:CD006419:CD006419-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_t/tCD006419-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Deworming drugs versus placebo; all trials, Outcome 3 Difference in mortality events between treatment and no treatment groups." data-id="CD006419-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Deworming drugs versus placebo; all trials, Outcome 3 Difference in mortality events between treatment and no treatment groups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/references#CD006419-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/media/CDSR/CD006419/image_n/nCD006419-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006419-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings for participants with unknown helminth infection status</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Deworming drugs compared with placebo for people with HIV and an unknown helminth infection status</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Participant or population:</b> HIV‐positive people </p> <p><b>Settings:</b> urban and rural areas co‐endemic for helminths and HIV </p> <p><b>Intervention:</b> deworming drugs (albendazole or praziquantel or a combination) </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Deworming drugs</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Viral load</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>At 6 weeks after a single dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>166</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<sup>1,2,3,4</sup> <br/> low </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>in the control group, the mean change in viral load was an increase of</p> <p><b>0.09 log<sub>10</sub> viral RNA</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, with deworming, there was a suppressive effect on mean viral load of</p> <p><b>0.14 log<sub>10</sub> viral RNA</b> </p> <p>(0.35 benefit to 0.07 harm)</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>At 2 years after multiple doses</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>917</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<sup>1,2,5,6</sup> <br/> moderate </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the control group, the mean viral load increased by</p> <p><b>0.03 log<sub>10</sub> viral RNA</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, with deworming, there was a suppressive effect on mean viral load of</p> <p><b>0.01 log<sub>10</sub> viral RNA</b> </p> <p>(0.03 benefit to 0.05 harm)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>CD4+ cell count</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>At 2 years after multiple doses</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>917</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<sup>1,2,4,5</sup> <br/> low </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the control group, the mean CD4+ cell count reduced by</p> <p><b>37.3 CD4+ cells/µL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, with deworming, there was a favourable effect on mean CD4+ cell count of </p> <p><b>2.60 CD4+ cells/µL</b> </p> <p>(15.35 benefit 10.15 harm)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (for example, the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>RNA:</b> ribonucleic acid; <b>HIV:</b> human immunodeficiency virus. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>1</sup>No serious risk of bias: this single trial was at low risk of selection bias.<br/> <sup>2</sup>No serious inconsistency: this was not applicable as there was only a single trial.<br/> <sup>3</sup>We downgraded by 1 for serious indirectness: this single trial is based upon a specific sample of pregnant women treated with albendazole or praziquantel, or both. The overall finding of an effect cannot be easily generalized to all populations or settings.<br/> <sup>4</sup>We downgraded by 1 for imprecision: the 95% CI includes potentially clinically important differences as well as no effect. Further larger studies are needed.<br/> <sup>5</sup>We downgraded by 1 for serious indirectness: this trial was conducted in three sites in rural and urban Kenya. Helminth infection was expected to be high but was not assessed at baseline. The findings are not easily generalized to all helminth endemic settings.<br/> <sup>6</sup>No serious imprecision: the 95% CI includes no effect but is narrow around the estimate and excludes clinically important differences. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings for participants with unknown helminth infection status</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006419-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings for participants with confirmed helminth infections</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Deworming drugs compared with placebo for people with HIV and confirmed helminth infections</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Participant or population:</b> HIV‐positive people with proven helminth infection </p> <p><b>Settings:</b> urban and rural areas co‐endemic for helminths and HIV </p> <p><b>Intervention:</b> deworming drugs (albendazole, praziquantel, albendazole and praziquantel, or diethylcarbamazine) </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (trials)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Deworming drugs</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Viral load</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>At 6 to 12 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>445</p> <p>(4 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1,2,3,4</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the control groups, the mean change in viral load ranged from</p> <p><b>a 0.13 decrease to an increase of 0.21 log<sub>10</sub> viral RNA</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, with deworming, there was a small suppressive effect on mean viral load of </p> <p><b>0.13 log<sub>10</sub> viral RNA</b> </p> <p>(0.26 benefit to 0.00 benefit)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>CD4+ cell count</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>At 6 to 12 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>358</p> <p>(3 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2,5,6,7</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the control groups, the mean change in CD4+ cell count ranged from</p> <p><b>a decrease of 68 to an increase of 45 CD4+ cells/µL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, with deworming, there was favourable effect on mean CD4+ cell count of</p> <p><b>37.86 CD4+ cells/µL</b> </p> <p>(7.36 benefit to 68.35 benefit)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (for example, the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>RNA:</b> ribonucleic acid; <b>HIV:</b> human immunodeficiency virus. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>1</sup>We downgraded by 1 for serious risk of bias: of the five studies, only one had CIs that excluded the possibility of no effect and this study was at high risk of selection bias.<br/> <sup>2</sup>No serious inconsistency: statistical heterogeneity was low.<br/> <sup>3</sup>We downgraded by 1 for serious indirectness: the only trial for which the CIs excluded the possibility of no effect administered praziquantel to people with schistosomiasis. The overall finding of an effect cannot be easily generalized to all deworming drugs, helminth infections, or settings.<br/> <sup>4</sup>No serious imprecision: the overall 95% CI is wide and includes both clinically important effects and no effect. However, as potential harm is excluded, we did not further downgrade the evidence.<br/> <sup>5</sup>No serious risk of bias: one trial was at high risk of selection bias, but excluding this trial did not substantially change the result.<br/> <sup>6</sup>We downgraded by 1 for serious indirectness: the included trials are from a very limited number of settings and participants. The overall finding is not easily generalized to all deworming drugs, helminth infections, or settings, and further trials are needed.<br/> <sup>7</sup>We downgraded by 1 for imprecision: the 95% CI is wide and includes potentially clinically important differences as well as no effect. Further larger studies are needed. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings for participants with confirmed helminth infections</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006419-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings for secondary outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Deworming drugs compared with placebo for people with HIV and both known and unknown helminth infection status</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Participant or population:</b> HIV‐positive people </p> <p><b>Settings:</b> urban and rural areas co‐endemic for helminths and HIV </p> <p><b>Intervention:</b> deworming drugs (albendazole, praziquantel, albendazole and praziquantel, or diethylcarbamazine) </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Albendazole</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Iron deficiency (serum ferritin)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>log<sub>10</sub> mean increase of 0.04 µg/L </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>log<sub>10</sub> mean increase of 0.07 µg/L </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Deworming drugs associated with a 0.03 higher µg/L log<sub>10</sub> mean ferritin measure (0.30 lower to 0.35 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<sup>1,2,3,4</sup> <br/> very low </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anaemia (serum haemoglobin)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Increase in 0.15 g/dL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Decrease in 0.10 g/dL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Deworming drugs associated with a 0.25 lower g/dL haemoglobin</p> <p>(0.58 lower to 0.08 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<sup>2,4,5,6</sup> <br/> very low </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>52 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.77</b> </p> <p>(0.52 to 1.14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1627</p> <p>(5 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>7,8,9,10</sup> <br/> low </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.23</b> </p> <p>(0.53 to 2.83)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1649</p> <p>(7 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<sup>4,9,11,12</sup> <br/> very low </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>HIV:</b> human immunodeficiency virus. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>No serious risk of bias: this single trial was at risk of selection bias. However, the outcome is an objective laboratory measure. We did not downgrade the quality of the evidence.<br/> <sup>2</sup>No serious inconsistency: not applicable as this is a single trial.<br/> <sup>3</sup>We downgraded by 2 for serious indirectness: this single trial is based upon a very small sample size of people treated with diethylcarbamazine for lymphatic filariasis. The overall finding of an effect can not be easily generalized to all deworming drugs, helminth infections, or settings.<br/> <sup>4</sup>We downgraded by 1 for imprecision: the 95% CI is wide and includes potentially clinically important differences as well as no effect. Larger studies are needed.<br/> <sup>5</sup>We downgraded by 1 for serious risk of bias: this single trial was at high risk of selection bias.<br/> <sup>6</sup>Downgraded by 1 for serious indirectness: this single trial is based upon a very small sample size of people treated with praziquantel for schistosomiasis. The overall finding of an effect can not be easily generalized to all deworming drugs or helminth infections or settings.<br/> <sup>7</sup>No serious risk of bias: although some of the trials are at risk of selection bias the outcome is an objective measure. We did not downgrade the evidence.<br/> <sup>8</sup>No serious inconsistency: statistical heterogeneity was low.<br/> <sup>9</sup>No serious indirectness: these trials took place in different settings, with different drugs, and with different helminth infections present. However, effects of treatment were consistent across the trials.<br/> <sup>10</sup>We downgraded by 2 for imprecision: the 95% CI is wide and includes potentially clinically important differences as well as no effect. Additionally the trials were not powered to detect changes in the rare outcome of mortality. A trial in which 3% of controls died would require a sample size of 7648 participants to attain 80% power to detect a 33% reduction in mortality.<br/> <sup>11</sup>We downgraded by 2 for serious risk of bias: it is unclear how some of the trial authors defined adverse events and thus there is risk of bias in outcome assessment.<br/> <sup>12</sup>No serious inconsistency: however, the analysis has an I² statistic value of 34%, which may represent low to moderate heterogeneity. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings for secondary outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Cochrane librarian search strategy for MEDLINE</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Search (HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tiab] OR hiv‐1*[tiab] OR hiv‐2*[tiab] OR hiv1[tiab] OR hiv2[tiab] OR hiv infect*[tiab] OR human immunodeficiency virus[tiab] OR human immunedeficiency virus[tiab] OR human immuno‐deficiency virus[tiab] OR human immune‐deficiency virus[tiab] OR ((human immun*[tiab]) AND (deficiency virus[tiab])) OR acquired immunodeficiency syndrome[tiab] OR acquired immunedeficiency syndrome[tiab] OR acquired immuno‐deficiency syndrome[tiab] OR acquired immune‐deficiency syndrome[tiab] OR ((acquired immun*[tiab]) AND (deficiency syndrome[tiab])) OR "sexually transmitted diseases, Viral"[MeSH:NoExp])) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Search (randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo [tiab] OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab]) NOT (animals [mh] NOT humans [mh]) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Search (helminths[mh] OR helminth*[tiab] OR nematode*[tiab] OR worm*[tiab] OR parasites[mh] OR parasit*[tiab] OR round worm*[tiab] OR roundworm*[tiab] OR hookworm*[tiab] OR hook worm*[tiab] OR ancylostoma*[tiab] OR cestode*[tiab] OR tapeworm*[tiab] OR tape worm*[tiab] OR trematode*[tiab] OR fluke*[tiab] OR whipworm*[tiab] OR whip worm*[tiab] OR trichuris[tiab] OR ascaris[tiab] OR enterobi*[tiab] OR strongyloide*[tiab] OR mansonell*[tiab] OR taenia[tiab] schistosom*[tiab] OR necator*[tiab] OR paragonim*[tiab] OR hymenolepis[tiab] OR fasciol*[tiab] OR filariasis[tiab] OR trichostrongl*[tiab] OR microfilaria[tiab] OR parasitic diseases[mh:noexp] OR helminthiasis[mh] OR intestinal diseases, parasitic[mh]) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Search (benzimidazoles OR albendazole OR mebendazole OR ivermectin OR praziquantel OR diethylcarbamazine OR bithionol OR oxamniquine OR pyrantel OR nitazoxanide OR anthelmintic OR anthelmintics OR anthelminthic OR anthelminthics OR “anti helminthic” OR “anti helminthics” OR “anti helmintic” OR “anti helmintics” OR antihelminthic OR antihelminthics OR antihelmintic OR antihelmintics) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Search (#1 AND #2 AND #3 AND #4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Search (((#1 AND #2 AND #3 AND #4))) AND ("1980/01/01"[Date ‐ Publication] : "2015/09/29"[Date ‐ Publication]) </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Cochrane librarian search strategy for MEDLINE</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0005"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Cochrane librarian search strategy for EMBASE</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'human immunodeficiency virus infection' exp OR 'human immunodeficiency virus infection':ab,ti OR 'hiv infection':ab,ti OR 'hiv infections':ab,ti OR 'human immunodeficiency virus'/exp OR 'human immunodeficiency virus':ab,ti OR hiv:ab,ti OR 'hiv 1':ab,ti OR 'hiv 2':ab,ti OR 'human immune deficiency virus':ab,ti OR 'human immuno deficiency virus':ab,ti OR 'acquired immunodeficiency syndrome':ab,ti OR 'acquired immuno deficiency syndrome':ab,ti OR 'acquired immune deficiency syndrome':ab,ti OR 'acquired immunedeficiency syndrome':ab,ti </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'randomized controlled trial'/de OR 'randomized controlled trial' OR random*:ab,ti OR trial:ti OR allocat*:ab,ti OR factorial*:ab,ti OR placebo*:ab,ti OR assign*:ab,ti OR volunteer*:ab,ti OR 'crossover procedure'/de OR 'crossover procedure'OR 'double‐blind procedure'/de OR 'double‐blind procedure' OR 'single‐blind procedure'/de OR 'single‐blind procedure' OR (doubl*NEAR/3 blind*):ab,ti OR (singl*:ab,ti AND blind*:ab,ti) OR crossover*:ab,ti OR cross+over*:ab,ti OR (crossNEXT/1 over*):ab,ti </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'animal'/de OR 'animal experiment'/de OR 'invertebrate'/de OR 'animal tissue'/de OR 'animal cell'/de OR 'nonhuman'/de </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'human'/de OR 'normal human'/de OR 'human cell'/de</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3 AND #4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3 NOT #5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2 NOT #6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'helminth'/exp OR helminth*:ab,ti OR nematode*:ab,ti OR worm*:ab,ti OR 'parasite'/exp OR parasit*:ab,ti OR roundAND worm*:ab,ti OR roundworm*:ab,ti OR hookworm*:ab,ti OR hookAND worm*:ab,ti OR ancylostoma*:ab,ti OR cestode*:ab,ti OR tapeworm*:ab,ti OR tapeAND worm*:ab,ti OR trematode*:ab,ti OR fluke*:ab,ti OR whipworm*:ab,ti OR whipAND worm*:ab,ti OR trichuris:ab,ti OR ascaris:ab,ti OR enterobi*:ab,ti OR strongyloide*:ab,ti OR mansonell*:ab,ti OR taenia:ab,ti AND schistosom*:ab,ti OR necator*:ab,ti OR paragonim*:ab,ti OR hymenolepis:ab,ti OR fasciol*:ab,ti OR filariasis:ab,ti OR trichostrongl*:ab,ti OR microfilaria:ab,ti OR 'parasitic diseases'/exp OR 'helminthiasis'/de OR 'intestine infection'/de </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'benzimidazoles'/de OR benzimidazolesOR 'albendazole'/de OR albendazoleOR 'mebendazole'/de OR mebendazoleOR 'ivermectin'/de OR ivermectinOR 'praziquantel'/de OR praziquantelOR 'diethylcarbamazine'/de OR diethylcarbamazineOR 'bithionol'/de OR bithionolOR 'oxamniquine'/de OR oxamniquineOR 'pyrantel'/de OR pyrantelOR 'nitazoxanide'/de OR nitazoxanideOR 'anthelmintic'/de OR anthelminticOR 'anthelmintics'/de OR anthelminticsOR 'anthelminthic'/de OR anthelminthicOR anthelminthicsOR 'anti helminthic'OR 'anti helminthics'OR 'anti helmintic'OR 'anti helmintics'OR antihelminthicOR antihelminthicsOR 'antihelmintic'/de OR antihelminticOR 'antihelmintics'/de OR antihelmintics </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #7 AND #8 AND #9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #7 AND #8 AND #9 AND [1‐1‐1980]/sd NOT [29‐09‐2015]/sd</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Cochrane librarian search strategy for EMBASE</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0006"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Cochrane librarian search strategy for CENTRAL</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MeSH descriptor: [HIV Infections] explode all trees</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MeSH descriptor: [HIV] explode all trees</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>hiv or hiv‐1* or hiv‐2* or hiv1 or hiv2 or (hiv near infect*) or (human immunodeficiency virus) or (human immunedeficiency virus) or (human immune‐deficiency virus) or (human immuno‐deficiency virus) or (human immune deficiency virus) or (human immuno deficiency virus) or (acquired immunodeficiency syndrome) or (acquired immunedeficiency syndrome) or (acquired immuno‐deficiency syndrome) or (acquired immune‐deficiency syndrome) or (acquired immun* deficiency syndrome) (Word variations have been searched) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MeSH descriptor: [Lymphoma, AIDS‐Related] this term only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MeSH descriptor: [Sexually Transmitted Diseases, Viral] this term only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 or #2 or #3 or #4 or #5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>[mh helminths] or helminth*:ti,ab,kw or meatode*:ti,ab,kw or worm*:ti,ab,kw or [mh parasites] or parasit*:ti,ab,kw or round worm:ti,ab,kw or roundworm:ti,ab,kw or hook worm*:ti,ab,kw or hookworm*:ti,ab,kw or ancylostoma*:ti,ab,kw or cestode*:ti,ab,kw or tapeworm*:ti,ab,kw or tape worm*:ti,ab,kw or trematode*:ti,ab,kw or fluke*:ti,ab,kw or whipworm*:ti,ab,kw or whip worm*:ti,ab,kw or trichuris:ti,ab,kw or ascaris:ti,ab,kw or enterobi*:ti,ab,kw or strongyloide*:ti,ab,kw or mansonell*:ti,ab,kw or taenia:ti,ab,kw schistosom*:ti,ab,kw or necator*:ti,ab,kw or paragonim*:ti,ab,kw or hymenolepis:ti,ab,kw or fasciol*:ti,ab,kw or filariasis:ti,ab,kw or trichostrongl*:ti,ab,kw or microfilaria:ti,ab,kw or [mh ^"parasitic diseases"] or [mh helminthiasis] or [mh ^"intestinal diseases, parasitic"] (Word variations have been searched) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>benzimidazoles or albendazole or mebendazole or ivermectin or praziquantel or diethylcarbamazine or bithionol or oxamniquine or pyrantel or nitazoxanide or anthelmintic or anthelmintics or anthelminthic or anthelminthics or "anti helminthic" or "anti helminthics" or "anti helmintic" or "anti helmintics" or antihelminthic or antihelminthics or antihelmintic or antihelmintics (Word variations have been searched) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6 and #7 and #8 Publication Year from 1980 to 2015, in Trials</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Cochrane librarian search strategy for CENTRAL</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0007"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Cochrane librarian search strategy for the WHO ICTRP</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HIV AND HELMINTH</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Cochrane librarian search strategy for the WHO ICTRP</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0008"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Cochrane librarian search strategy for clinicaltrials.gov</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HIV AND HELMINTH | Interventional Studies | received from 01/01/1980 to 09/29/2015</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Cochrane librarian search strategy for clinicaltrials.gov</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0009"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Search terms used in 2009 newly applied in MEDLINE</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“HIV Infections”[MeSH] OR “HIV”[MeSH] OR hiv [tw] OR hiv‐1*[tw] OR hiv‐2*[tw] OR hiv1[tw] OR hiv2[tw] OR hiv infect*[tw] OR human immunodeficiency virus[tw] OR human immunedeficiency virus[tw] OR human immunodeficiency virus[tw] OR human immune‐deficiency virus[tw] OR ((human immun*) AND (deficiency virus[tw])) OR acquired immunodeficiency syndrome[tw] OR acquired immunedeficiency syndrome[tw] OR acquired immunodeficiency syndrome[tw] OR acquired immune‐deficiency syndrome[tw] OR ((acquired immun*) AND (deficiency syndrome[tw])) OR “Sexually Transmitted Diseases, Viral”[MeSH:NoExp] </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized controlled trials [mh] OR random allocation [mh] OR double‐blind method [mh] OR single‐blind method [mh] OR clinical trial [pt] OR clinical trials [mh] OR (“clinical trial” [tw]) OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR (placebos [mh] OR placebo* [tw] OR random* [tw] OR research design [mh:noexp] OR comparative study [mh] OR evaluation studies [mh] OR follow‐up studies [mh] OR prospective studies [mh] OR control* [tw] OR prospectiv* [tw] OR volunteer* [tw]) NOT (animals [mh] NOT human [mh]) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HELMINTHS OR ROUNDWORM OR ROUND WORM OR ROUND‐WORM OR ROUNDWORMS OR ROUND WORMS OR ROUND‐WORMS OR NEMATODES OR NEMATODE OR CESTODE OR CESTODES OR TAPEWORM OR TAPE WORM OR TAPE‐WORM OR TAPEWORMS OR TAPE WORMS OR TAPE‐WORMS OR TREMATODE OR TREMATODES OR FLUKE OR FLUKES OR WORM OR WORMS OR PARASITE OR PARASITES OR ASCARIS OR TRICHURIS OR ENTEROBIUS OR STRONGYLOIDE OR STRONGYLOIDES OR ANCYLOSTOMA OR ANCYLOSTOMAS OR NECATOR OR NECATORS OR HYMENOLEPIS OR PARAGONIMUS OR FASCIOLA OR TAENIA OR HOOKWORM OR HOOK WORM OR HOOK‐WORM OR HOOKWORMS OR HOOK WORMS OR HOOK‐WORMS OR WHIPWORM OR WHIP WORM OR WHIP‐WORM OR WHIPWORMS OR WHIP WORMS OR WHIP‐WORMS OR SCHISTOSOMIASIS OR MANSONELLA OR FILARIASIS OR MICROFILARIA OR TRICHOSTRONGYLUS OR TRICHOSTRONGYLOSIS OR STRONGYLOIDEA OR PARAGONIMIASIS </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BENZIMIDAZOLES OR ALBENDAZOLE OR MEBENDAZOLE OR IVERMECTIN OR PRAZIQUANTEL OR DIETHYLCARBAMAZINE OR BITHIONOL OR OXAMNIQUINE OR PYRANTEL OR NITAZOXANIDE </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3 AND #4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #2 AND #5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #2 AND #5 Limits: Publication Date from 1980 to 2015/09/29</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Search terms used in 2009 newly applied in MEDLINE</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0010"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Search terms used in 2009 newly applied in EMBASE</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>((’human immunodeficiency virus infection’/exp OR ’human immunodeficiency virus infection’) OR (’human immunodeficiency virus infection’/exp OR ’human immunodeficiency virus infection’)) OR ((’human immunodeficiency virus’/exp OR ’human immunodeficiency virus’) OR (’human immunodeficiency virus’/exp OR ’human immunodeficiency virus’)) OR (hiv:ti OR hiv:ab) OR (’hiv‐1’:ti OR ’hiv‐1’:ab) OR (’hiv‐2’:ti OR ’hiv‐2’:ab) OR (’human immunodeficiency virus’:ti OR ’human immunodeficiency virus’:ab) OR (’human immuno‐deficiency virus’:ti OR ’human immuno‐deficiency virus’:ab) OR (’human immunedeficiency virus’:ti OR ’human immunedeficiency virus’:ab) OR (’human immune‐deficiency virus’:ti OR ’human immune‐deficiency virus’:ab) OR (’acquired immune‐deficiency syndrome’:ti OR ’acquired immune‐deficiency syndrome’:ab) OR (’acquired immunedeficiency syndrome’:ti OR ’acquired immunedeficiency syndrome’:ab) OR (’acquired immunodeficiency syndrome’:ti OR ’acquired immunodeficiency syndrome’:ab) OR (’acquired immuno‐deficiency syndrome’:ti OR ’acquired immuno‐deficiency syndrome’:ab) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>random:ti OR random:ab OR factorial:ti OR factorial*:ab OR 'cross over':ti OR 'cross over':ab OR crossover:ti OR crossover:ab OR placebo:ti OR placebo:ab OR (double:ti AND blind:ti) OR (doubl:ab AND blind*:ab) OR (single:ti AND blind:ti) OR (single:ab AND blind:ab) OR assign:ti OR assign:ab OR allocat:ti OR allocate:ab OR volunteer:ti OR volunteer:ab OR 'crossover procedure'/exp OR 'crossover procedure' OR 'double‐blind procedure'/exp OR 'double‐blind procedure' OR 'single‐blind procedure'/exp OR 'single‐blind procedure' OR 'randomized controlled trial'/exp OR 'randomized controlled trial' </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'helminths' OR 'roundworm' OR 'round worm' OR 'round‐worm' OR roundworms OR 'round worms' OR 'round‐worms' OR nematodes OR 'nematode' OR 'cestode' OR cestodes OR 'tapeworm' OR 'tape worm' OR 'tape‐worm' OR tapeworms OR 'tape worms' OR 'tape‐worms' OR 'trematode' OR trematodes OR 'fluke' OR flukes OR 'worm' OR worms OR 'parasite' OR 'parasites' OR 'ascaris' OR 'trichuris' OR 'enterobius' OR strongyloide OR stronglyloides OR 'ancylostoma' OR ancylostomas OR 'necator' OR necators OR 'hymenolepis' OR 'paragonimus' OR 'fasciola' OR 'taenia' OR 'hookworm' OR 'hook worm' OR 'hook‐worm' OR hookworms OR 'hook worms' OR 'hook‐worms' OR 'whipworm' OR 'whip worm' OR 'whip‐worm' OR whipworms OR 'whip worms' OR 'whip‐worms' OR shistosomiasis OR 'mansonella' OR 'filariasis' OR 'microfilaria' OR 'trichostrongylus' OR trichostronglylosis OR stronglyloidea OR pargonimiasis </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>((’benzimidazoles’/exp OR ’benzimidazoles’) OR (’benzimidazoles’/exp OR ’benzimidazoles’)) OR ((’albendazole’/exp OR ’albendazole’) OR (’albendazole’/exp OR ’albendazole’)) OR ((’mebendazole’/exp OR ’mebendazole’) OR (’mebendazole’/exp OR ’mebendazole’)) OR ((’ivermectin’/exp OR ’ivermectin’) OR (’ivermectin’/exp OR ’ivermectin’)) OR ((’praziquantel’/exp OR ’praziquantel’) OR (’praziquantel’/exp OR ’praziquantel’)) OR ((’diethylcarbamazine’/exp OR ’diethylcarbamazine’) OR (’diethylcarbamazine’/exp OR ’diethylcarbamazine’)) OR ((’bithionol’/exp OR ’bithionol’) OR (’bithionol’/exp OR ’bithionol’)) OR ((’oxamniquine’/exp OR ’oxamniquine’) OR (’oxamniquine’/exp OR ’oxamniquine’)) OR ((’pyrantel’/exp OR ’pyrantel’) OR (’pyrantel’/exp OR ’pyrantel’)) OR ((’nitazoxanide’/exp OR ’nitazoxanide’) OR (’nitazoxanide’/exp OR ’nitazoxanide’)) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3 OR #4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #2 AND #5 [1‐1‐1980]/sd NOT [29‐09‐2015]/sd</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Search terms used in 2009 newly applied in EMBASE</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0011"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Search terms used in 2009 newly applied in CENTRAL</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(HIV INFECTIONS) OR HIV OR HIV OR HIV‐1* OR HIV‐2* OR HIV1 OR HIV2 OR (HIV INFECT*) OR (HUMAN IMMUNODEFICIENCY VIRUS) OR (HUMAN IMMUNEDEFICIENCY VIRUS) OR (HUMAN IMMUNO‐DEFICIENCY VIRUS) OR (HUMAN IMMUNE‐DEFICIENCY VIRUS) OR ((HUMAN IMMUN*) AND (DEFICIENCY VIRUS)) OR (ACQUIRED IMMUNODEFICIENCY SYNDROME) OR (ACQUIRED IMMUNEDEFICIENCY SYNDROME) OR (ACQUIRED IMMUNO‐DEFICIENCY SYNDROME) OR (ACQUIRED IMMUNE‐DEFICIENCY SYNDROME) OR ((ACQUIRED IMMUN*) AND (DEFICIENCY SYNDROME)) OR (VIRAL SEXUALLY TRANSMITTED DISEASES) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HELMINTHS OR ROUNDWORM OR ROUND WORM OR ROUND‐WORM OR ROUNDWORMS OR ROUND WORMS OR ROUND‐WORMS OR NEMATODES OR NEMATODE OR CESTODE OR CES‐TODES OR TAPEWORM OR TAPE WORM OR TAPE‐WORM OR TAPEWORMS OR TAPE WORMS OR TAPE‐WORMS OR TREMATODE OR TREMATODES OR FLUKE OR FLUKES OR WORM OR WORMS OR PARASITE OR PARASITES OR ASCARIS OR TRICHURIS OR ENTEROBIUS OR STRONGYLOIDE OR STRONGYLOIDES OR ANCYLOSTOMA OR ANCYLOSTOMAS OR NECATOR OR NECATORS OR HYMENOLEPIS OR PARAGONIMUS OR FASCIOLA OR TAENIA OR HOOKWORM OR HOOK WORM OR HOOK‐WORM OR HOOKWORMS OR HOOK WORMS OR HOOK‐WORMS OR WHIPWORM OR WHIP WORM OR WHIP‐WORM OR WHIPWORMS OR WHIP WORMS OR WHIP‐WORMS OR SCHISTOSOMIASIS OR MANSONELLA OR FILARIASIS OR MICROFILARIA OR TRICHOSTRONGYLUS OR TRICHOSTRONGYLOSIS OR STRONGYLOIDEA OR PARAGONIMIASIS </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BENZIMIDAZOLES OR ALBENDAZOLE OR MEBENDAZOLE OR IVERMECTIN OR PRAZIQUANTEL OR DIETHYLCARBAMAZINE OR BITHIONOL OR OXAMNIQUINE OR PYRANTEL OR NITAZOXANIDE </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2 OR #3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #4 from 1980 to 2015</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Search terms used in 2009 newly applied in CENTRAL</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0012"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Search terms used in 2009 newly applied in AIDSEARCH</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(HIV INFECTIONS) OR HIV OR HIV OR HIV‐1* OR HIV‐2* OR HIV1 OR HIV2 OR (HIV INFECT*) OR (HUMAN IMMUNODEFICIENCY VIRUS) OR (HUMAN IMMUNEDEFICIENCY VIRUS) OR (HUMAN IMMUNO‐DEFICIENCY VIRUS) OR (HUMAN IMMUNE‐DEFICIENCY VIRUS) OR ((HUMAN IMMUN*) AND (DEFICIENCY VIRUS)) OR (ACQUIRED IMMUNODEFICIENCY SYNDROME) OR (ACQUIRED IMMUNEDEFICIENCY SYNDROME) OR (ACQUIRED IMMUNO‐DEFICIENCY SYNDROME) OR (ACQUIRED IMMUNE‐DEFICIENCY SYNDROME) OR ((ACQUIRED IMMUN*) AND (DEFICIENCY SYNDROME)) OR (SEXUALLY TRANSMITTED DISEASES, VIRAL) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>((RANDOMIZED CONTROLLED TRIAL) OR (CONTROLLED CLINICAL TRIAL) OR (RANDOMIZED CONTROLLED TRIALS) OR (RANDOM ALLOCATION) OR (DOUBLE‐BLIND METHOD) OR (SINGLE‐ BLIND METHOD) OR (CLINICAL TRIAL) OR (CLINICAL TRIALS) OR (“CLINICAL TRIAL”) OR ((SINGL* OR DOUBL* OR TREBL* OR TRIPL* AND (MASK* OR BLIND*)) OR PLACEBOS OR PLACEBO* OR RANDOM* OR (COMPARATIVE STUDY) OR (EVALUATION STUDIES) OR (FOLLOW‐UP STUDIES) OR (PROSPECTIVE STUDIES) OR CONTROL* OR PROSPECTIV* OR VOLUNTEER*)) NOT (ANIMALS NOT HUMAN) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#1 AND #2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HELMINTHS OR ROUNDWORM OR ROUND WORM OR ROUND‐WORM OR ROUNDWORMS OR ROUND WORMS OR ROUND‐WORMS OR NEMATODES OR NEMATODE OR CESTODE OR CES‐TODES OR TAPEWORM OR TAPE WORM OR TAPE‐WORM OR TAPEWORMS OR TAPE WORMS OR TAPE‐WORMS OR TREMATODE OR TREMATODES OR FLUKE OR FLUKES OR WORM OR WORMS OR PARASITE OR PARASITES OR ASCARIS OR TRICHURIS OR ENTEROBIUS OR STRONGYLOIDE OR STRONGYLOIDES OR ANCYLOSTOMA OR ANCYLOSTOMAS OR NECATOR OR NECATORS </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HYMENOLEPIS OR PARAGONIMUS OR FASCIOLA OR TAENIA OR HOOKWORM OR HOOK WORM OR HOOK‐WORM OR HOOKWORMS OR HOOK WORMS OR HOOK‐WORMS OR WHIPWORM OR WHIP WORM OR WHIP‐WORM OR WHIPWORMS OR WHIP WORMS OR WHIP‐WORMS OR SCHISTOSOMIASIS OR MANSONELLA OR FILARIASIS OR MICROFILARIA OR TRICHOSTRONGYLUS OR TRICHOSTRONGYLOSIS OR STRONGYLOIDEA OR PARAGONIMIASIS </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BENZIMIDAZOLES OR ALBENDAZOLE OR MEBENDAZOLE OR IVERMECTIN OR PRAZIQUANTEL OR DIETHYLCARBAMAZINE OR BITHIONOL OR OXAMNIQUINE OR PYRANTEL OR NITAZOXANIDE </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#4 OR #5 OR #6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>#7 AND #3</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Search terms used in 2009 newly applied in AIDSEARCH</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0013"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Search strategy for the WHO Global Health Library</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Search terms</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>#1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Helminth* AND "HIV Infections" received from 01/01/1980 to 09/29/2015</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Search strategy for the WHO Global Health Library</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0014"> <div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Characteristics of trials in which participants had unknown helminth infection status</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Year enrolment completed</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Inclusion criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total randomized</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number HIV‐positive participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Taking ART</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number co‐infected with helminths at baseline</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zambia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urban</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected adults with persistent diarrhoea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated (probably low)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uganda</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urban</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected pregnant women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67% had at least 1 helminth species</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenya</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urban/rural</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected, not on ART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>948</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>948</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None at baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><b>Abbreviations</b>: HIV: human immunodeficiency virus; ART: antiretroviral. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Characteristics of trials in which participants had unknown helminth infection status</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0015"> <div class="table-heading"><span class="table-label">Table 12.</span> <span class="table-title">Description of interventions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Timing</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Drug</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Frequency</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. ">Walson 2008 KEN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Albendazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once daily for 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Viral load</p> <p>CD4</p> <p>Adverse events</p> <p>Mortality events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. ">Abate 2014 ETH</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Albendazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once daily for 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CD4</p> <p>Adverse events</p> <p>Mortality events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. ">Kallestrup 2005 ZWE</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Praziquantel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Viral load</p> <p>CD4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. ">Nielsen 2007 TZA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diethylcarbamazine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Viral load</p> <p>CD4</p> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0003" title="KellyP , LunguF , KeaneE , BaggaleyR , KazembeF , PobeeJ , et al. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. BMJ1996;312(7040):1187‐91. ">Kelly 1996 ZMB</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Albendazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice daily for 14 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> <p>Mortality events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0005" title="SuputtamongkolY , PremasathianN , BhumimuangK , WaywaD , NilganuwongS , KaruphongE , et al. Efficacy and safety of single and double doses of ivermectin versus 7‐day high dose albendazole for chronic strongyloidiasis. PLoS Neglected Tropical Diseases2011;5(5):e1044. ">Suputtamongkol 2011 THA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ivermectin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single or double dose 2 weeks apart</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Albendazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 year</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0008" title="WebbEL , Kyosiimire‐LugemwaJ , KizitoD , NkurunzizaP , LuleS , MuhangiL , et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double‐blind, placebo‐controlled trial in Uganda. Journal of Acquired Immune Deficiency Syndromes2012;60(3):307‐13. ">Webb 2012 UGA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Albendazole</p> <p>Praziquantel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 mg</p> <p>40 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once only</p> <p>Once only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Viral load</p> <p>Adverse events</p> <p>Mortality events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0007" title="WalsonJ , SingaB , SangaréL , NaulikhaJ , PiperB , RichardsonB , et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi‐site, randomised trial. The Lancet Infectious diseases2012;12(12):925‐32. [PUBMED: 22971323] ">Walson 2012 KEN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Albendazole</p> <p>Praziquantel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 mg</p> <p>25 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Every 3 months</p> <p>Annually</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Viral load</p> <p>CD4</p> <p>Adverse events</p> <p>Mortality events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 years</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 12.</span> <span class="table-title">Description of interventions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0016"> <div class="table-heading"><span class="table-label">Table 13.</span> <span class="table-title">Characteristics of trials in which participants had confirmed helminth infections</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Year enrolment completed</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Inclusion criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total randomized</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of HIV‐positive participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Taking ART</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number co‐infected with helminths at baseline</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0006" title="WalsonJL , OtienoPA , MbuchiM , RichardsonBA , Lohman‐PayneB , MachariaSW , et al. Albendazole treatment of HIV‐1 and helminth co‐infection: a randomized, double‐blind, placebo‐controlled trial. AIDS2008;22(13):1601‐9. "><b>Walson 2008 KEN</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenya</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urban/rural</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected with at least one helminth co‐infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None at baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0001" title="AbateE , EliasD , GetachewA , AlemuS , DiroE , BrittonS , et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co‐infected tuberculosis patients: a double blind randomised clinical trial. International Journal for Parasitology2014;45(2‐3):133‐40. "><b>Abate 2014 ETH</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ethiopia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urban</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Newly diagnosed TB participants with helminth co‐infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 to 60 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94% of intervention group, 100% of controls</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0002" title="KallestrupP , ZinyamaR , GomoE , ButterworthAE , MudengeB , vanDamGJ , et al. Schistosomiasis and HIV‐1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV‐1 RNA load. The Journal of Infectious Diseases2005;192(11):1956‐61. "><b>Kallestrup 2005 ZWE</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zimbabwe</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rural</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults infected with schistosomiasis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0004" title="NielsenNO , SimonsenPE , DalgaardP , KrarupH , MagnussenP , MagesaS , et al. Effect of diethycarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV‐infected adult Tanzanians with or without lymphatic filariasis: randomized double‐blind and placebo‐controlled cross‐over trial. American Journal of Tropical Medicine and Hygiene2007;77(3):507‐13. NielsenNO , SimonsenPE , KaestelP , KrarupH , MagnussenP , MagesaS , et al. Micronutrient status indicators in individuals single‐ or double‐infected with HIV and Wuchereria bancrofti before and after DEC treatment. Tropical Medicine &amp; International Health2009;14(1):44‐53. "><b>Nielsen 2007 TZA</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tanzania</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rural</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22 to 70 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006419-bbs2-0005" title="SuputtamongkolY , PremasathianN , BhumimuangK , WaywaD , NilganuwongS , KaruphongE , et al. Efficacy and safety of single and double doses of ivermectin versus 7‐day high dose albendazole for chronic strongyloidiasis. PLoS Neglected Tropical Diseases2011;5(5):e1044. "><b>Suputtamongkol 2011 THA</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thailand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urban</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults with characteristic strongyloides infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><b>Abbreviations:</b> HIV: human immunodeficiency virus; ART: antiretroviral; TB: tuberculosis. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 13.</span> <span class="table-title">Characteristics of trials in which participants had confirmed helminth infections</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006419-tbl-0017"> <div class="table-heading"><span class="table-label">Table 14.</span> <span class="table-title">Ongoing or planned RCTs</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial name</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relevant intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relevant outcome</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Target population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Location(s)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Estimated completion date</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reduction of EArly mortaLITY in HIV‐infected Adults and Children Starting Antiretroviral Therapy (REALITY) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Immediate enhanced opportunistic infections (OI) prophylaxis with isoniazid/pyridoxine and cotrimoxazole, plus 12 weeks fluconazole, 5 days azithromycin, and a single dose of albendazole versus cotrimoxazole prophylaxis alone for the first 12 weeks followed by isoniazid and any prophylaxis and/or treatment prescribed at screening </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>• Change in CD4 count</p> <p>• Adverse events</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected individuals ages ≥ 5 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenya, Malawi, Uganda, Zimbabwe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>February 2016</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Can Anthelminthic Treatment Delay the Progression of HIV? Randomised Open‐label Trial Testing Presumptive Anthelminthic Treatment on Progression of HIV in ART‐naïve HIV‐positive Patients in a Rural African Setting With Presumed High Prevalence of Helminth Infections </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard HIV care with provision of praziquantel, albendazole, and ivermectin at baseline, after 6 months, and after 12 months versus standard HIV care with no anthelminthic treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>• Change in viral load</p> <p>• Change in CD4 count</p> <p>• Adverse event</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HIV‐infected individuals aged ≥ 18 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tanzania</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Terminated prematurely due to recruitment difficulties</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><b>Abbreviations:</b> RCT: randomized controlled trial; HIV: human immunodeficiency virus; ART: antiretroviral. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 14.</span> <span class="table-title">Ongoing or planned RCTs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/full#CD006419-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006419-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Deworming drugs versus placebo in people with unknown helminth infection status</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Viral load: change in log<sub>10</sub> HIV‐1 RNA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 At 6 weeks after one dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.35, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 At 2 years after multiple doses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>917</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.03, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in CD4 count <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>917</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.60 [‐10.15, 15.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 At 2 years after multiple doses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>917</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.60 [‐10.15, 15.35]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Deworming drugs versus placebo in people with unknown helminth infection status</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/references#CD006419-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006419-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Deworming drugs versus placebo in people with confirmed helminth infection</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Viral load: change in log<sub>10</sub> HIV‐1 RNA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.26, ‐0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Soil‐transmitted helminths</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>273</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.31, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Schistosomiasis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.36, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Lymphatic filariasis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.93, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in CD4 count <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>37.86 [7.36, 68.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Soil‐transmitted helminths</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>40.69 [1.51, 79.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Schistosomiasis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>33.5 [‐15.06, 82.06]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Deworming drugs versus placebo in people with confirmed helminth infection</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/references#CD006419-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006419-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Deworming drugs versus placebo; all trials</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in log<sub>10</sub> HIV RNA, by antihelminthic <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1534</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.19, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Albendazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.37, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Praziquantel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.32, ‐0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Diethylcarbamazine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.93, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Albendazole and praziquantel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.04, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Difference in adverse events between treatment and no treatment groups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1649</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.53, 2.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Difference in mortality events between treatment and no treatment groups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.52, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Deworming drugs versus placebo; all trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006419.pub4/references#CD006419-tbl-0020">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006419.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006419-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006419-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD006419-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD006419-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD006419-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006419-note-0014">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006419\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006419\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006419\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006419\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006419\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006419.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006419.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006419.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006419.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006419.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727816452"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006419.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727816456"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006419.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eb54f7cb09368',t:'MTc0MDcyNzgxNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 